User login
License to slip up?
The Food and Drug Administration recently approved another weight-loss drug (Contrave), a combination of naltrexone (indicated for opioid dependence) and bupropion (indicated for depression). This is the third weight-loss drug approved in the past 2 years. The FDA previously approved lorcaserin (Belviq) and topiramate/phentermine (Qsymia). This approval activity signals pharmaceutical interest in a multibillion dollar weight loss industry and perhaps, maybe less so, the FDA’s recognition of our public health crisis.
For patients who meet criteria for the use of these medications, they should be offered if they can be afforded. However, these medications may make patients behave differently.
It’s called “license.”
License is the psychological phenomenon in which people who feel they have made progress toward a goal feel liberated to make an incongruent choice. Think of a patient interested in losing weight who now takes a weight-loss pill. Despite not having lost any weight yet and perhaps just after taking the first pill, the patient then makes a choice to consume a high-calorie dessert.
Here are some data that support that this could be happening.
One team of investigators randomized subjects to being informed they were taking a placebo or a weight-loss supplement (which was actually the same placebo tablet as in the other study arm). After receiving the supplement, participants were allowed access to a reward buffet lunch at which their food consumption was recorded. Compared with controls, participants receiving a purported weight-loss supplement ate more food at the reward buffet. This effect seemed to occur through a perceived sense that they were making progress toward their weight-loss goal by taking the pill (Nutrition 2014;30:1007-14).
This is critical for us to think about and incorporate into our clinical teaching when prescribing these medications. Psychological liberation threatens any health gains we can make at a population level with any weight-loss approach. We need to help our patients understand that these medications should be used in combination with sustainable lifestyle changes or they may as well be taking a placebo.
Dr. Ebbert is professor of medicine, a general internist at the Mayo Clinic in Rochester, Minn., and a diplomate of the American Board of Addiction Medicine. The opinions expressed are those of the author. The opinions expressed in this article should not be used to diagnose or treat any medical condition nor should they be used as a substitute for medical advice from a qualified, board-certified practicing clinician.
The Food and Drug Administration recently approved another weight-loss drug (Contrave), a combination of naltrexone (indicated for opioid dependence) and bupropion (indicated for depression). This is the third weight-loss drug approved in the past 2 years. The FDA previously approved lorcaserin (Belviq) and topiramate/phentermine (Qsymia). This approval activity signals pharmaceutical interest in a multibillion dollar weight loss industry and perhaps, maybe less so, the FDA’s recognition of our public health crisis.
For patients who meet criteria for the use of these medications, they should be offered if they can be afforded. However, these medications may make patients behave differently.
It’s called “license.”
License is the psychological phenomenon in which people who feel they have made progress toward a goal feel liberated to make an incongruent choice. Think of a patient interested in losing weight who now takes a weight-loss pill. Despite not having lost any weight yet and perhaps just after taking the first pill, the patient then makes a choice to consume a high-calorie dessert.
Here are some data that support that this could be happening.
One team of investigators randomized subjects to being informed they were taking a placebo or a weight-loss supplement (which was actually the same placebo tablet as in the other study arm). After receiving the supplement, participants were allowed access to a reward buffet lunch at which their food consumption was recorded. Compared with controls, participants receiving a purported weight-loss supplement ate more food at the reward buffet. This effect seemed to occur through a perceived sense that they were making progress toward their weight-loss goal by taking the pill (Nutrition 2014;30:1007-14).
This is critical for us to think about and incorporate into our clinical teaching when prescribing these medications. Psychological liberation threatens any health gains we can make at a population level with any weight-loss approach. We need to help our patients understand that these medications should be used in combination with sustainable lifestyle changes or they may as well be taking a placebo.
Dr. Ebbert is professor of medicine, a general internist at the Mayo Clinic in Rochester, Minn., and a diplomate of the American Board of Addiction Medicine. The opinions expressed are those of the author. The opinions expressed in this article should not be used to diagnose or treat any medical condition nor should they be used as a substitute for medical advice from a qualified, board-certified practicing clinician.
The Food and Drug Administration recently approved another weight-loss drug (Contrave), a combination of naltrexone (indicated for opioid dependence) and bupropion (indicated for depression). This is the third weight-loss drug approved in the past 2 years. The FDA previously approved lorcaserin (Belviq) and topiramate/phentermine (Qsymia). This approval activity signals pharmaceutical interest in a multibillion dollar weight loss industry and perhaps, maybe less so, the FDA’s recognition of our public health crisis.
For patients who meet criteria for the use of these medications, they should be offered if they can be afforded. However, these medications may make patients behave differently.
It’s called “license.”
License is the psychological phenomenon in which people who feel they have made progress toward a goal feel liberated to make an incongruent choice. Think of a patient interested in losing weight who now takes a weight-loss pill. Despite not having lost any weight yet and perhaps just after taking the first pill, the patient then makes a choice to consume a high-calorie dessert.
Here are some data that support that this could be happening.
One team of investigators randomized subjects to being informed they were taking a placebo or a weight-loss supplement (which was actually the same placebo tablet as in the other study arm). After receiving the supplement, participants were allowed access to a reward buffet lunch at which their food consumption was recorded. Compared with controls, participants receiving a purported weight-loss supplement ate more food at the reward buffet. This effect seemed to occur through a perceived sense that they were making progress toward their weight-loss goal by taking the pill (Nutrition 2014;30:1007-14).
This is critical for us to think about and incorporate into our clinical teaching when prescribing these medications. Psychological liberation threatens any health gains we can make at a population level with any weight-loss approach. We need to help our patients understand that these medications should be used in combination with sustainable lifestyle changes or they may as well be taking a placebo.
Dr. Ebbert is professor of medicine, a general internist at the Mayo Clinic in Rochester, Minn., and a diplomate of the American Board of Addiction Medicine. The opinions expressed are those of the author. The opinions expressed in this article should not be used to diagnose or treat any medical condition nor should they be used as a substitute for medical advice from a qualified, board-certified practicing clinician.
Death by discontinuity of care
The story
SJ was a 66-year-old woman with a history of ulcerative colitis (UC) who was recently status post laparoscopic proctocolectomy with ileoanal J pouch and diverting ileostomy 2 weeks ago at Hospital A. At the time of her surgical discharge, she was tolerating an oral diet, but over the next 2 weeks her oral intake declined, she reported feeling light-headed with movement, and she had an increase in abdominal pain despite oral analgesia. SJ was at her surgical follow-up appointment when she passed out in the waiting room. She awoke spontaneously, but she was hypotensive and was taken by ambulance to the emergency room of Hospital B. On examination SJ was very orthostatic. She had blood drawn, and she had an ECG, an abdominal radiograph, and a CT scan of the abdomen and pelvis performed. Her ECG and abdominal imaging were unremarkable. She was found to have an elevated lipase (910 U/dL) and low hemoglobin (9.9 mg/dL), although her anemia was not significantly different from 2 weeks ago. SJ was sent from Hospital B to Hospital C and admitted by Dr. Hospitalist 1 (nighttime, weekend coverage) for dehydration and possible pancreatitis. Dr. Hospitalist 1 initiated intravenous fluids and ordered an ultrasound of the abdomen. Intermittent pneumatic compression devices were ordered for deep vein thrombosis prophylaxis.
The following morning, SJ was seen by Dr. Hospitalist 2 (daytime, weekend coverage). On examination, SJ was noted to have bilateral lower extremity edema. She remained orthostatic despite several liters of saline. Dr. Hospitalist 2 ordered a CT scan of the chest with a PE protocol along with ultrasonography of the legs. SJ’s morning hemoglobin was 8.4 mg/dL and Dr. Hospitalist 2 ordered a blood transfusion. The results of the imaging returned the next day and both the CT and lower extremity ultrasounds were normal. However, the abdominal ultrasound ordered by Dr. Hospitalist 1 incidentally identified an inferior vena cava filter (IVCF) with a small amount of adherent clot.
The next day, SJ was seen by Dr. Hospitalist 3 (daytime, weekday attending). SJ’s hemoglobin was now 10.4 mg/dL and her lipase was normal. Dr. Hospitalist 3 documented that SJ was doing “better,” and that the plan was to wean IV fluids, work with physical therapy, and discharge soon. But SJ continued to complain of abdominal tightness, burning in her legs, and light-headedness with activity. On hospital day 4, Dr. Hospitalist 3 ordered oral antibiotics for possible leg cellulitis. On hospital day 5, SJ passed out briefly during physical therapy and Dr. Hospitalist 3 increased her IV fluids. Over the next 3 days, Dr. Hospitalist 3 stopped and restarted the IV fluids several times.
On hospital day 8, SJ was seen by Dr. Hospitalist 4 (daytime, weekend coverage). SJ remained orthostatic. Dr. Hospitalist 4 ordered a CT of the abdomen to evaluate the IVCF, which identified thrombus material within the IVCF and the entire caudal vena cava, iliac, and femoral vessels. Full-dose anticoagulation was initiated with low-molecular-weight heparin. On hospital day 10, SJ collapsed in physical therapy and lost her pulse. A full code blue response, including systemic TPA administration, failed to revive her and she was pronounced dead. An autopsy was performed and determined pulmonary embolism as the cause of death.
Complaint
SJ’s husband had difficulty reconciling the fact that SJ died so recently after her surgical discharge and that she had been considered “well on her way” to a full recovery. The case was referred to an attorney and subsequent review supported medical negligence and a complaint was filed. The complaint alleged that the Hospitalists (specifically 1, 2, and 3) failed to recognize SJ’s increased risk for thrombosis, failed to diagnose her IVC obstruction, and failed to initiate appropriate treatment in the form of therapeutic anticoagulation. Had the standard of care been followed, the complaint alleged, SJ would not have died.
Scientific principles
Inferior vena cava obstruction has been reported in 3%-30% of patients following IVC filter placement related to new local thrombus formation, thrombogenicity of the device, trapped embolus, or extension of a more distal DVT cephalad. Patients with inferior vena caval thrombosis (IVCT) may present with a spectrum of signs and symptoms and this variability is a significant part of the challenge of diagnosis. The classic presentation of IVCT includes bilateral lower extremity edema with dilated, visible superficial abdominal veins.
Complaint rebuttal and discussion
The Hospitalists defended themselves by providing reasonable alternatives to the actual diagnosis. SJ had a new ileostomy and orthostasis is common in such patients. Yet SJ did not have documented high stoma outputs and her electrolytes and renal function were inconsistent with hypovolemia.
Defense experts also pointed to SJ’s anemia and orthostasis and opined that anticoagulation would be contraindicated until hemorrhage could be ruled out. Yet SJ’s anemia was not significantly different from her surgical discharge and SJ was on anticoagulant DVT prophylaxis her entire surgical hospitalization with even lower levels of hemoglobin.
Plaintiff experts asserted that the Hospitalists should have contacted SJ’s colorectal surgeon if they were reluctant to use anticoagulants to further inform the risks and benefits. Ultimately, the defense had little explanation for the Hospitalists’ collective failure to follow-up on the abdominal ultrasound that demonstrated a small amount of adherent clot.
Conclusion
SJ was at two different hospitals and had four different Hospitalist s in 10 days.
Dr. Hospitalist 1 never saw the radiology films from Hospital B that showed an IVCF. When Dr. Hospitalist 2 began caring for SJ, he was unaware that SJ even had an IVCF or that she had a prior history of PE. Over the weekend, Dr. Hospitalist 2 did not access the labs from Hospital A to see if SJ’s anemia was new or not. Dr. Hospitalist 3 did not know that Dr. Hospitalist 1 ordered an abdominal ultrasound on admission and because the result was not flagged as “abnormal” the small adherent clot on the IVCF was not integrated into SJ’s clinical presentation.
All Hospitalist groups struggle to provide continuity in a system of discontinuity. In this case, important details were missed and it led to a delay in diagnosis and ultimately treatment.
This case was settled for an undisclosed amount on behalf of the plaintiff.
Dr. Michota is director of academic affairs in the hospital medicine department at the Cleveland Clinic and medical editor of Hospitalist News. He has been involved in peer review both within and outside the legal system. Read past columns at eHospitalist news.com/Lessons.
The story
SJ was a 66-year-old woman with a history of ulcerative colitis (UC) who was recently status post laparoscopic proctocolectomy with ileoanal J pouch and diverting ileostomy 2 weeks ago at Hospital A. At the time of her surgical discharge, she was tolerating an oral diet, but over the next 2 weeks her oral intake declined, she reported feeling light-headed with movement, and she had an increase in abdominal pain despite oral analgesia. SJ was at her surgical follow-up appointment when she passed out in the waiting room. She awoke spontaneously, but she was hypotensive and was taken by ambulance to the emergency room of Hospital B. On examination SJ was very orthostatic. She had blood drawn, and she had an ECG, an abdominal radiograph, and a CT scan of the abdomen and pelvis performed. Her ECG and abdominal imaging were unremarkable. She was found to have an elevated lipase (910 U/dL) and low hemoglobin (9.9 mg/dL), although her anemia was not significantly different from 2 weeks ago. SJ was sent from Hospital B to Hospital C and admitted by Dr. Hospitalist 1 (nighttime, weekend coverage) for dehydration and possible pancreatitis. Dr. Hospitalist 1 initiated intravenous fluids and ordered an ultrasound of the abdomen. Intermittent pneumatic compression devices were ordered for deep vein thrombosis prophylaxis.
The following morning, SJ was seen by Dr. Hospitalist 2 (daytime, weekend coverage). On examination, SJ was noted to have bilateral lower extremity edema. She remained orthostatic despite several liters of saline. Dr. Hospitalist 2 ordered a CT scan of the chest with a PE protocol along with ultrasonography of the legs. SJ’s morning hemoglobin was 8.4 mg/dL and Dr. Hospitalist 2 ordered a blood transfusion. The results of the imaging returned the next day and both the CT and lower extremity ultrasounds were normal. However, the abdominal ultrasound ordered by Dr. Hospitalist 1 incidentally identified an inferior vena cava filter (IVCF) with a small amount of adherent clot.
The next day, SJ was seen by Dr. Hospitalist 3 (daytime, weekday attending). SJ’s hemoglobin was now 10.4 mg/dL and her lipase was normal. Dr. Hospitalist 3 documented that SJ was doing “better,” and that the plan was to wean IV fluids, work with physical therapy, and discharge soon. But SJ continued to complain of abdominal tightness, burning in her legs, and light-headedness with activity. On hospital day 4, Dr. Hospitalist 3 ordered oral antibiotics for possible leg cellulitis. On hospital day 5, SJ passed out briefly during physical therapy and Dr. Hospitalist 3 increased her IV fluids. Over the next 3 days, Dr. Hospitalist 3 stopped and restarted the IV fluids several times.
On hospital day 8, SJ was seen by Dr. Hospitalist 4 (daytime, weekend coverage). SJ remained orthostatic. Dr. Hospitalist 4 ordered a CT of the abdomen to evaluate the IVCF, which identified thrombus material within the IVCF and the entire caudal vena cava, iliac, and femoral vessels. Full-dose anticoagulation was initiated with low-molecular-weight heparin. On hospital day 10, SJ collapsed in physical therapy and lost her pulse. A full code blue response, including systemic TPA administration, failed to revive her and she was pronounced dead. An autopsy was performed and determined pulmonary embolism as the cause of death.
Complaint
SJ’s husband had difficulty reconciling the fact that SJ died so recently after her surgical discharge and that she had been considered “well on her way” to a full recovery. The case was referred to an attorney and subsequent review supported medical negligence and a complaint was filed. The complaint alleged that the Hospitalists (specifically 1, 2, and 3) failed to recognize SJ’s increased risk for thrombosis, failed to diagnose her IVC obstruction, and failed to initiate appropriate treatment in the form of therapeutic anticoagulation. Had the standard of care been followed, the complaint alleged, SJ would not have died.
Scientific principles
Inferior vena cava obstruction has been reported in 3%-30% of patients following IVC filter placement related to new local thrombus formation, thrombogenicity of the device, trapped embolus, or extension of a more distal DVT cephalad. Patients with inferior vena caval thrombosis (IVCT) may present with a spectrum of signs and symptoms and this variability is a significant part of the challenge of diagnosis. The classic presentation of IVCT includes bilateral lower extremity edema with dilated, visible superficial abdominal veins.
Complaint rebuttal and discussion
The Hospitalists defended themselves by providing reasonable alternatives to the actual diagnosis. SJ had a new ileostomy and orthostasis is common in such patients. Yet SJ did not have documented high stoma outputs and her electrolytes and renal function were inconsistent with hypovolemia.
Defense experts also pointed to SJ’s anemia and orthostasis and opined that anticoagulation would be contraindicated until hemorrhage could be ruled out. Yet SJ’s anemia was not significantly different from her surgical discharge and SJ was on anticoagulant DVT prophylaxis her entire surgical hospitalization with even lower levels of hemoglobin.
Plaintiff experts asserted that the Hospitalists should have contacted SJ’s colorectal surgeon if they were reluctant to use anticoagulants to further inform the risks and benefits. Ultimately, the defense had little explanation for the Hospitalists’ collective failure to follow-up on the abdominal ultrasound that demonstrated a small amount of adherent clot.
Conclusion
SJ was at two different hospitals and had four different Hospitalist s in 10 days.
Dr. Hospitalist 1 never saw the radiology films from Hospital B that showed an IVCF. When Dr. Hospitalist 2 began caring for SJ, he was unaware that SJ even had an IVCF or that she had a prior history of PE. Over the weekend, Dr. Hospitalist 2 did not access the labs from Hospital A to see if SJ’s anemia was new or not. Dr. Hospitalist 3 did not know that Dr. Hospitalist 1 ordered an abdominal ultrasound on admission and because the result was not flagged as “abnormal” the small adherent clot on the IVCF was not integrated into SJ’s clinical presentation.
All Hospitalist groups struggle to provide continuity in a system of discontinuity. In this case, important details were missed and it led to a delay in diagnosis and ultimately treatment.
This case was settled for an undisclosed amount on behalf of the plaintiff.
Dr. Michota is director of academic affairs in the hospital medicine department at the Cleveland Clinic and medical editor of Hospitalist News. He has been involved in peer review both within and outside the legal system. Read past columns at eHospitalist news.com/Lessons.
The story
SJ was a 66-year-old woman with a history of ulcerative colitis (UC) who was recently status post laparoscopic proctocolectomy with ileoanal J pouch and diverting ileostomy 2 weeks ago at Hospital A. At the time of her surgical discharge, she was tolerating an oral diet, but over the next 2 weeks her oral intake declined, she reported feeling light-headed with movement, and she had an increase in abdominal pain despite oral analgesia. SJ was at her surgical follow-up appointment when she passed out in the waiting room. She awoke spontaneously, but she was hypotensive and was taken by ambulance to the emergency room of Hospital B. On examination SJ was very orthostatic. She had blood drawn, and she had an ECG, an abdominal radiograph, and a CT scan of the abdomen and pelvis performed. Her ECG and abdominal imaging were unremarkable. She was found to have an elevated lipase (910 U/dL) and low hemoglobin (9.9 mg/dL), although her anemia was not significantly different from 2 weeks ago. SJ was sent from Hospital B to Hospital C and admitted by Dr. Hospitalist 1 (nighttime, weekend coverage) for dehydration and possible pancreatitis. Dr. Hospitalist 1 initiated intravenous fluids and ordered an ultrasound of the abdomen. Intermittent pneumatic compression devices were ordered for deep vein thrombosis prophylaxis.
The following morning, SJ was seen by Dr. Hospitalist 2 (daytime, weekend coverage). On examination, SJ was noted to have bilateral lower extremity edema. She remained orthostatic despite several liters of saline. Dr. Hospitalist 2 ordered a CT scan of the chest with a PE protocol along with ultrasonography of the legs. SJ’s morning hemoglobin was 8.4 mg/dL and Dr. Hospitalist 2 ordered a blood transfusion. The results of the imaging returned the next day and both the CT and lower extremity ultrasounds were normal. However, the abdominal ultrasound ordered by Dr. Hospitalist 1 incidentally identified an inferior vena cava filter (IVCF) with a small amount of adherent clot.
The next day, SJ was seen by Dr. Hospitalist 3 (daytime, weekday attending). SJ’s hemoglobin was now 10.4 mg/dL and her lipase was normal. Dr. Hospitalist 3 documented that SJ was doing “better,” and that the plan was to wean IV fluids, work with physical therapy, and discharge soon. But SJ continued to complain of abdominal tightness, burning in her legs, and light-headedness with activity. On hospital day 4, Dr. Hospitalist 3 ordered oral antibiotics for possible leg cellulitis. On hospital day 5, SJ passed out briefly during physical therapy and Dr. Hospitalist 3 increased her IV fluids. Over the next 3 days, Dr. Hospitalist 3 stopped and restarted the IV fluids several times.
On hospital day 8, SJ was seen by Dr. Hospitalist 4 (daytime, weekend coverage). SJ remained orthostatic. Dr. Hospitalist 4 ordered a CT of the abdomen to evaluate the IVCF, which identified thrombus material within the IVCF and the entire caudal vena cava, iliac, and femoral vessels. Full-dose anticoagulation was initiated with low-molecular-weight heparin. On hospital day 10, SJ collapsed in physical therapy and lost her pulse. A full code blue response, including systemic TPA administration, failed to revive her and she was pronounced dead. An autopsy was performed and determined pulmonary embolism as the cause of death.
Complaint
SJ’s husband had difficulty reconciling the fact that SJ died so recently after her surgical discharge and that she had been considered “well on her way” to a full recovery. The case was referred to an attorney and subsequent review supported medical negligence and a complaint was filed. The complaint alleged that the Hospitalists (specifically 1, 2, and 3) failed to recognize SJ’s increased risk for thrombosis, failed to diagnose her IVC obstruction, and failed to initiate appropriate treatment in the form of therapeutic anticoagulation. Had the standard of care been followed, the complaint alleged, SJ would not have died.
Scientific principles
Inferior vena cava obstruction has been reported in 3%-30% of patients following IVC filter placement related to new local thrombus formation, thrombogenicity of the device, trapped embolus, or extension of a more distal DVT cephalad. Patients with inferior vena caval thrombosis (IVCT) may present with a spectrum of signs and symptoms and this variability is a significant part of the challenge of diagnosis. The classic presentation of IVCT includes bilateral lower extremity edema with dilated, visible superficial abdominal veins.
Complaint rebuttal and discussion
The Hospitalists defended themselves by providing reasonable alternatives to the actual diagnosis. SJ had a new ileostomy and orthostasis is common in such patients. Yet SJ did not have documented high stoma outputs and her electrolytes and renal function were inconsistent with hypovolemia.
Defense experts also pointed to SJ’s anemia and orthostasis and opined that anticoagulation would be contraindicated until hemorrhage could be ruled out. Yet SJ’s anemia was not significantly different from her surgical discharge and SJ was on anticoagulant DVT prophylaxis her entire surgical hospitalization with even lower levels of hemoglobin.
Plaintiff experts asserted that the Hospitalists should have contacted SJ’s colorectal surgeon if they were reluctant to use anticoagulants to further inform the risks and benefits. Ultimately, the defense had little explanation for the Hospitalists’ collective failure to follow-up on the abdominal ultrasound that demonstrated a small amount of adherent clot.
Conclusion
SJ was at two different hospitals and had four different Hospitalist s in 10 days.
Dr. Hospitalist 1 never saw the radiology films from Hospital B that showed an IVCF. When Dr. Hospitalist 2 began caring for SJ, he was unaware that SJ even had an IVCF or that she had a prior history of PE. Over the weekend, Dr. Hospitalist 2 did not access the labs from Hospital A to see if SJ’s anemia was new or not. Dr. Hospitalist 3 did not know that Dr. Hospitalist 1 ordered an abdominal ultrasound on admission and because the result was not flagged as “abnormal” the small adherent clot on the IVCF was not integrated into SJ’s clinical presentation.
All Hospitalist groups struggle to provide continuity in a system of discontinuity. In this case, important details were missed and it led to a delay in diagnosis and ultimately treatment.
This case was settled for an undisclosed amount on behalf of the plaintiff.
Dr. Michota is director of academic affairs in the hospital medicine department at the Cleveland Clinic and medical editor of Hospitalist News. He has been involved in peer review both within and outside the legal system. Read past columns at eHospitalist news.com/Lessons.
Newborn jaundice app shows promise
An investigational smartphone app performed similarly to a transcutaneous bilirubinometer to screen for newborn jaundice in a pilot study of 100 babies. Measurements from the BiliCam app yielded a rank order correlation of 0.85 with the gold standard blood test to measure total serum bilirubin levels. Transcutaneous bilirubinometer readings had a rank order correlation of 0.92 with total serum bilirubin levels, according to data presented by investigators from the University of Washington, Seattle, at the Association for Computing Machinery’s International Joint Conference on Pervasive and Ubiquitous Computing (UbiComp2014).
The BiliCam had a mean error of 2 mg/dL and transcutaneous bilirubinometer readings had a mean error of 1.5 mg/dL, compared with total serum bilirubin levels, Dr. James W. Stout said in an interview.
The BiliCam “compared favorably” with transcutaneous bilirubinometry, according to the investigators, Dr. Stout and Dr. James A. Taylor, both professors of pediatrics at the university.
“Where we’re at now is very much a work in progress. It will almost certainly perform better as the data set grows” to 400-500 and eventually 1,000 babies, Dr. Stout said. “The way it performs now is more than anything a promising signal about how we think it can perform.”
Getting the BiliCam into the hands of clinicians in general within a year is an “optimistic” goal, and “I feel pretty confident we can have this out in the world in 2 years,” he said. Food and Drug Administration approval would be needed before parents could use the BiliCam at home, he added.
If it pans out, the BiliCam could be more accessible and less expensive than transcutaneous bilirubinometers, which cost $7,000-$8,000, he said. The expensive devices usually aren’t found in general pediatric offices and certainly aren’t used by many parents at home.
In the study, users downloaded the app to an iPhone 4, placed a business card–size color-calibration card on the baby’s belly, and triggered the app to take photos with the card in view. The app sent the data to the Cloud for analysis by algorithms, and a report on the newborn’s bilirubin levels was sent almost instantly to the user’s phone. All babies were tested between 2-5 days of age using the BiliCam, a transcutaneous bilirubinometer, and serum testing.
Although an estimated 84% of newborns develop jaundice, only approximately 20 U.S. babies per year develop kernicterus from severe jaundice, Dr. Stout said. Visual assessment, even by experienced clinicians, has been shown to be only moderately accurate, at best, for estimating the severity of jaundice, leading many parents to return to clinics with “yellow babies” who are not really at risk but may undergo blood draws, he said. “We want to reduce the churn.”
More importantly, the investigators hope that the BiliCam eventually will prove useful in resource-poor nations where kernicterus causes many newborn deaths, he added. Before that can happen, the BiliCam must be tested on more racially diverse populations so that the algorithms can extract the relevant wavelengths to incorporate into the app. “We don’t know yet that we can do that in really dark babies,” he said.
Other testing should begin within the year to adapt the BiliCam to other types of phones beyond iPhones. The investigator are exploring infrastructures for national and international trials.
Grants from the Coulter Foundation and the National Science Foundation funded the research. The investigators and the university have filed a patent on BiliCam, which is expected to generate future revenue from fees for the app or for processing photos, or from coverage by insurers or some other commercial model.
On Twitter @sherryboschert
An investigational smartphone app performed similarly to a transcutaneous bilirubinometer to screen for newborn jaundice in a pilot study of 100 babies. Measurements from the BiliCam app yielded a rank order correlation of 0.85 with the gold standard blood test to measure total serum bilirubin levels. Transcutaneous bilirubinometer readings had a rank order correlation of 0.92 with total serum bilirubin levels, according to data presented by investigators from the University of Washington, Seattle, at the Association for Computing Machinery’s International Joint Conference on Pervasive and Ubiquitous Computing (UbiComp2014).
The BiliCam had a mean error of 2 mg/dL and transcutaneous bilirubinometer readings had a mean error of 1.5 mg/dL, compared with total serum bilirubin levels, Dr. James W. Stout said in an interview.
The BiliCam “compared favorably” with transcutaneous bilirubinometry, according to the investigators, Dr. Stout and Dr. James A. Taylor, both professors of pediatrics at the university.
“Where we’re at now is very much a work in progress. It will almost certainly perform better as the data set grows” to 400-500 and eventually 1,000 babies, Dr. Stout said. “The way it performs now is more than anything a promising signal about how we think it can perform.”
Getting the BiliCam into the hands of clinicians in general within a year is an “optimistic” goal, and “I feel pretty confident we can have this out in the world in 2 years,” he said. Food and Drug Administration approval would be needed before parents could use the BiliCam at home, he added.
If it pans out, the BiliCam could be more accessible and less expensive than transcutaneous bilirubinometers, which cost $7,000-$8,000, he said. The expensive devices usually aren’t found in general pediatric offices and certainly aren’t used by many parents at home.
In the study, users downloaded the app to an iPhone 4, placed a business card–size color-calibration card on the baby’s belly, and triggered the app to take photos with the card in view. The app sent the data to the Cloud for analysis by algorithms, and a report on the newborn’s bilirubin levels was sent almost instantly to the user’s phone. All babies were tested between 2-5 days of age using the BiliCam, a transcutaneous bilirubinometer, and serum testing.
Although an estimated 84% of newborns develop jaundice, only approximately 20 U.S. babies per year develop kernicterus from severe jaundice, Dr. Stout said. Visual assessment, even by experienced clinicians, has been shown to be only moderately accurate, at best, for estimating the severity of jaundice, leading many parents to return to clinics with “yellow babies” who are not really at risk but may undergo blood draws, he said. “We want to reduce the churn.”
More importantly, the investigators hope that the BiliCam eventually will prove useful in resource-poor nations where kernicterus causes many newborn deaths, he added. Before that can happen, the BiliCam must be tested on more racially diverse populations so that the algorithms can extract the relevant wavelengths to incorporate into the app. “We don’t know yet that we can do that in really dark babies,” he said.
Other testing should begin within the year to adapt the BiliCam to other types of phones beyond iPhones. The investigator are exploring infrastructures for national and international trials.
Grants from the Coulter Foundation and the National Science Foundation funded the research. The investigators and the university have filed a patent on BiliCam, which is expected to generate future revenue from fees for the app or for processing photos, or from coverage by insurers or some other commercial model.
On Twitter @sherryboschert
An investigational smartphone app performed similarly to a transcutaneous bilirubinometer to screen for newborn jaundice in a pilot study of 100 babies. Measurements from the BiliCam app yielded a rank order correlation of 0.85 with the gold standard blood test to measure total serum bilirubin levels. Transcutaneous bilirubinometer readings had a rank order correlation of 0.92 with total serum bilirubin levels, according to data presented by investigators from the University of Washington, Seattle, at the Association for Computing Machinery’s International Joint Conference on Pervasive and Ubiquitous Computing (UbiComp2014).
The BiliCam had a mean error of 2 mg/dL and transcutaneous bilirubinometer readings had a mean error of 1.5 mg/dL, compared with total serum bilirubin levels, Dr. James W. Stout said in an interview.
The BiliCam “compared favorably” with transcutaneous bilirubinometry, according to the investigators, Dr. Stout and Dr. James A. Taylor, both professors of pediatrics at the university.
“Where we’re at now is very much a work in progress. It will almost certainly perform better as the data set grows” to 400-500 and eventually 1,000 babies, Dr. Stout said. “The way it performs now is more than anything a promising signal about how we think it can perform.”
Getting the BiliCam into the hands of clinicians in general within a year is an “optimistic” goal, and “I feel pretty confident we can have this out in the world in 2 years,” he said. Food and Drug Administration approval would be needed before parents could use the BiliCam at home, he added.
If it pans out, the BiliCam could be more accessible and less expensive than transcutaneous bilirubinometers, which cost $7,000-$8,000, he said. The expensive devices usually aren’t found in general pediatric offices and certainly aren’t used by many parents at home.
In the study, users downloaded the app to an iPhone 4, placed a business card–size color-calibration card on the baby’s belly, and triggered the app to take photos with the card in view. The app sent the data to the Cloud for analysis by algorithms, and a report on the newborn’s bilirubin levels was sent almost instantly to the user’s phone. All babies were tested between 2-5 days of age using the BiliCam, a transcutaneous bilirubinometer, and serum testing.
Although an estimated 84% of newborns develop jaundice, only approximately 20 U.S. babies per year develop kernicterus from severe jaundice, Dr. Stout said. Visual assessment, even by experienced clinicians, has been shown to be only moderately accurate, at best, for estimating the severity of jaundice, leading many parents to return to clinics with “yellow babies” who are not really at risk but may undergo blood draws, he said. “We want to reduce the churn.”
More importantly, the investigators hope that the BiliCam eventually will prove useful in resource-poor nations where kernicterus causes many newborn deaths, he added. Before that can happen, the BiliCam must be tested on more racially diverse populations so that the algorithms can extract the relevant wavelengths to incorporate into the app. “We don’t know yet that we can do that in really dark babies,” he said.
Other testing should begin within the year to adapt the BiliCam to other types of phones beyond iPhones. The investigator are exploring infrastructures for national and international trials.
Grants from the Coulter Foundation and the National Science Foundation funded the research. The investigators and the university have filed a patent on BiliCam, which is expected to generate future revenue from fees for the app or for processing photos, or from coverage by insurers or some other commercial model.
On Twitter @sherryboschert
Reaching the limits of disclosure
$11.38. What can you buy for that kind of money?
Not much, realistically: an entrée at a casual restaurant, a shirt on sale at Target, a few cases of Ramen noodles in college.
In my case, it was what (per the Internet) bought my time.
About a year ago, a friendly drug rep asked my secretary if he could bring a pizza for lunch. We don’t do rep lunches, but he’d overheard her telling me she’d forgotten lunch at home and was going to go out to McDonald’s.
He told her he wouldn’t stay to sell anything, so she said “Sure, thank you.” He got a small pizza, dropped it off for her, and left. She had a piece and took the rest home to her kids. I didn’t think much of it, although it was the only time in the last 2 years we’ve gotten anything besides samples from a rep.
I wasn’t planning on checking my Sunshine Act disclosure data, since I don’t see reps beyond signing for samples. But then I heard an old partner of mine had a plastic brain listed under his name ($18.36) by mistake when it had actually been given to another doc with a similar name.
So I logged in, and there it was. I’d accepted $11.38 in “food and beverage” (AKA, the pizza I never ate) from a drug company.
I can’t really dispute it, and it’s not that much money. I doubt anyone will think I’m for sale for such a pithy amount, and no reporter looking for a doctor bribery scandal is going to think it’s a story worth chasing.
I support disclosure. There are clearly many instances where the relationship between physicians and pharma has been abused for financial gains. Kickbacks and bribes are as old as society and will always be with us. Having outside scrutiny of our actions, at least in this instance, is likely good at keeping everyone honest. There will always be ways to cheat, but most of us aren’t looking for them.
But still, it irritates me that this seemingly innocent lunch for my secretary could be taken to mean something else.
So, the pizza I didn’t eat becomes an odd milestone in my medical career. I don’t remember when I had my first drug company lunch, but it was likely during my third year of medical school. But now, I, and anyone who wants to look it up, knows when my last one was an $11.38 pizza that I never had on Aug. 29, 2013.
Dr. Block has a solo neurology practice in Scottsdale, Ariz.
$11.38. What can you buy for that kind of money?
Not much, realistically: an entrée at a casual restaurant, a shirt on sale at Target, a few cases of Ramen noodles in college.
In my case, it was what (per the Internet) bought my time.
About a year ago, a friendly drug rep asked my secretary if he could bring a pizza for lunch. We don’t do rep lunches, but he’d overheard her telling me she’d forgotten lunch at home and was going to go out to McDonald’s.
He told her he wouldn’t stay to sell anything, so she said “Sure, thank you.” He got a small pizza, dropped it off for her, and left. She had a piece and took the rest home to her kids. I didn’t think much of it, although it was the only time in the last 2 years we’ve gotten anything besides samples from a rep.
I wasn’t planning on checking my Sunshine Act disclosure data, since I don’t see reps beyond signing for samples. But then I heard an old partner of mine had a plastic brain listed under his name ($18.36) by mistake when it had actually been given to another doc with a similar name.
So I logged in, and there it was. I’d accepted $11.38 in “food and beverage” (AKA, the pizza I never ate) from a drug company.
I can’t really dispute it, and it’s not that much money. I doubt anyone will think I’m for sale for such a pithy amount, and no reporter looking for a doctor bribery scandal is going to think it’s a story worth chasing.
I support disclosure. There are clearly many instances where the relationship between physicians and pharma has been abused for financial gains. Kickbacks and bribes are as old as society and will always be with us. Having outside scrutiny of our actions, at least in this instance, is likely good at keeping everyone honest. There will always be ways to cheat, but most of us aren’t looking for them.
But still, it irritates me that this seemingly innocent lunch for my secretary could be taken to mean something else.
So, the pizza I didn’t eat becomes an odd milestone in my medical career. I don’t remember when I had my first drug company lunch, but it was likely during my third year of medical school. But now, I, and anyone who wants to look it up, knows when my last one was an $11.38 pizza that I never had on Aug. 29, 2013.
Dr. Block has a solo neurology practice in Scottsdale, Ariz.
$11.38. What can you buy for that kind of money?
Not much, realistically: an entrée at a casual restaurant, a shirt on sale at Target, a few cases of Ramen noodles in college.
In my case, it was what (per the Internet) bought my time.
About a year ago, a friendly drug rep asked my secretary if he could bring a pizza for lunch. We don’t do rep lunches, but he’d overheard her telling me she’d forgotten lunch at home and was going to go out to McDonald’s.
He told her he wouldn’t stay to sell anything, so she said “Sure, thank you.” He got a small pizza, dropped it off for her, and left. She had a piece and took the rest home to her kids. I didn’t think much of it, although it was the only time in the last 2 years we’ve gotten anything besides samples from a rep.
I wasn’t planning on checking my Sunshine Act disclosure data, since I don’t see reps beyond signing for samples. But then I heard an old partner of mine had a plastic brain listed under his name ($18.36) by mistake when it had actually been given to another doc with a similar name.
So I logged in, and there it was. I’d accepted $11.38 in “food and beverage” (AKA, the pizza I never ate) from a drug company.
I can’t really dispute it, and it’s not that much money. I doubt anyone will think I’m for sale for such a pithy amount, and no reporter looking for a doctor bribery scandal is going to think it’s a story worth chasing.
I support disclosure. There are clearly many instances where the relationship between physicians and pharma has been abused for financial gains. Kickbacks and bribes are as old as society and will always be with us. Having outside scrutiny of our actions, at least in this instance, is likely good at keeping everyone honest. There will always be ways to cheat, but most of us aren’t looking for them.
But still, it irritates me that this seemingly innocent lunch for my secretary could be taken to mean something else.
So, the pizza I didn’t eat becomes an odd milestone in my medical career. I don’t remember when I had my first drug company lunch, but it was likely during my third year of medical school. But now, I, and anyone who wants to look it up, knows when my last one was an $11.38 pizza that I never had on Aug. 29, 2013.
Dr. Block has a solo neurology practice in Scottsdale, Ariz.
Careers: How to avoid the No. 1 physician job-search mistake and land your ideal job
In this article, let me show you the No. 1 mistake the vast majority of physicians make when looking for a position. When you avoid this mistake, you stand a much better chance of landing your ideal job.
Here is the physician job-search mistake in a nutshell: Do not search for a job the same way you applied to Medical School or Residency
If you do, your success in this employed position will rely purely on luck. Here is what I mean.
For most of us, the last experience we had of interviewing for a position was our application to Medical School and/or Residency. In this situation, we were basically doing anything we could to be accepted. We were saying, “Pick me, Pick me” and doing whatever it took to make it into the ranks of the chosen.
That is not what a job search is about. In fact, a healthy job search turns the tables 180 degrees – it is an awareness mind flip.
In your search for a permanent position, you want to make sure this is a place you will fit in – long term. In order to do that well, you must have an Ideal Job Description and be screening job opportunities to see if they fit your Ideal Job.
Now you are screening them ...
I have to repeat this because it is so important: You must know what you are looking for first and ask the questions required to screen them to see if they match your Ideal Job Description.
This process allows you to come home from your interview and make a high quality decision about this particular job offer. It is this simple: With your Ideal Job Description in one hand and the results of your interview in the other hand, you create a Venn diagram and measure the overlap.
Once you are able to make this comparison, you only have one decision to make: How much overlap is enough to say yes to this offer?
When you approach your physician job search in this fashion you are focused on what you want – Your Ideal Job, rather than taking any opportunity where you will be accepted. So ... what is your Ideal Job Description?
Most doctors have never created a description of their Ideal Job. We spend our time coping with the areas in our current position that are painful and anything other than “ideal.” Grab a pen and some paper. Imagine you have a Magic Wand in your hand ... you wave it and ... POOF, there’s your Dream Job in all of its glory.

Write down all the characteristics of your Ideal Job in as much detail as possible.
Here are some of the questions you will want to answer:
• What do you want to be doing - what kinds of patients and cases?
• In what setting?
• For how many hours a week?
• For what pay and benefits?
• In how big of a group?
• Where – in what area of what country?
• With what group culture and work environment?
• What are the characteristics you want in your boss?
• List all the pertinent positives and negatives.
• BOTH the things you want AND the things you want to make sure are NOT there.
This is a living document. You will add to it and subtract from it over time as you get more and more clear.
===========
Power Tip #1:
Write it down in ink on paper. Keep your Ideal Job Description in a folder with a nice label in a place so you will see it weekly. You will use this description in both your job search and in continuously improving any position you ultimately take.
You are taking something that exists only in your imagination and beginning the process of turning it into reality. The move from thought to physical pen strokes on physical paper is step No. 1. And I know this is “old school.” Try it for yourself.
Power Tip #2:
Write it down, even if you feel it is something that is “impossible.” Write it down anyway. It is a goal to shoot for that will shape your decision in a healthy way. There is no job that is a 100% overlap with your ideal. This does NOT mean you can’t aim in that direction.
Note: There are some specialties where the job market is so tight that you must still work hard to get accepted – radiology comes immediately to mind. This process works best in specialties that are in high demand at this time – especially Family Practice and all other forms of primary care.
Creating your Ideal Job Description and using it to drive your job search is Step No. 1 in getting the position you really want. In a future column, I will give you a set of questions you can ask in your job interview that will give you a clear read on the group’s culture, decision-making style and the quality of your immediate supervisor. With this information in hand, you will dramatically improve the odds that your next job is a permanent happy home for your practice.
===========
Guest contributor Dr. Dike Drummond, is a family physician, executive coach, and creator of the Burnout Prevention MATRIX Free Report with more than 117 different ways physicians and organizations can lower stress and prevent burnout. He provides stress management, burnout prevention, and physician wellness, and engagement coaching and consulting through his website, TheHappyMD.com.
In this article, let me show you the No. 1 mistake the vast majority of physicians make when looking for a position. When you avoid this mistake, you stand a much better chance of landing your ideal job.
Here is the physician job-search mistake in a nutshell: Do not search for a job the same way you applied to Medical School or Residency
If you do, your success in this employed position will rely purely on luck. Here is what I mean.
For most of us, the last experience we had of interviewing for a position was our application to Medical School and/or Residency. In this situation, we were basically doing anything we could to be accepted. We were saying, “Pick me, Pick me” and doing whatever it took to make it into the ranks of the chosen.
That is not what a job search is about. In fact, a healthy job search turns the tables 180 degrees – it is an awareness mind flip.
In your search for a permanent position, you want to make sure this is a place you will fit in – long term. In order to do that well, you must have an Ideal Job Description and be screening job opportunities to see if they fit your Ideal Job.
Now you are screening them ...
I have to repeat this because it is so important: You must know what you are looking for first and ask the questions required to screen them to see if they match your Ideal Job Description.
This process allows you to come home from your interview and make a high quality decision about this particular job offer. It is this simple: With your Ideal Job Description in one hand and the results of your interview in the other hand, you create a Venn diagram and measure the overlap.
Once you are able to make this comparison, you only have one decision to make: How much overlap is enough to say yes to this offer?
When you approach your physician job search in this fashion you are focused on what you want – Your Ideal Job, rather than taking any opportunity where you will be accepted. So ... what is your Ideal Job Description?
Most doctors have never created a description of their Ideal Job. We spend our time coping with the areas in our current position that are painful and anything other than “ideal.” Grab a pen and some paper. Imagine you have a Magic Wand in your hand ... you wave it and ... POOF, there’s your Dream Job in all of its glory.

Write down all the characteristics of your Ideal Job in as much detail as possible.
Here are some of the questions you will want to answer:
• What do you want to be doing - what kinds of patients and cases?
• In what setting?
• For how many hours a week?
• For what pay and benefits?
• In how big of a group?
• Where – in what area of what country?
• With what group culture and work environment?
• What are the characteristics you want in your boss?
• List all the pertinent positives and negatives.
• BOTH the things you want AND the things you want to make sure are NOT there.
This is a living document. You will add to it and subtract from it over time as you get more and more clear.
===========
Power Tip #1:
Write it down in ink on paper. Keep your Ideal Job Description in a folder with a nice label in a place so you will see it weekly. You will use this description in both your job search and in continuously improving any position you ultimately take.
You are taking something that exists only in your imagination and beginning the process of turning it into reality. The move from thought to physical pen strokes on physical paper is step No. 1. And I know this is “old school.” Try it for yourself.
Power Tip #2:
Write it down, even if you feel it is something that is “impossible.” Write it down anyway. It is a goal to shoot for that will shape your decision in a healthy way. There is no job that is a 100% overlap with your ideal. This does NOT mean you can’t aim in that direction.
Note: There are some specialties where the job market is so tight that you must still work hard to get accepted – radiology comes immediately to mind. This process works best in specialties that are in high demand at this time – especially Family Practice and all other forms of primary care.
Creating your Ideal Job Description and using it to drive your job search is Step No. 1 in getting the position you really want. In a future column, I will give you a set of questions you can ask in your job interview that will give you a clear read on the group’s culture, decision-making style and the quality of your immediate supervisor. With this information in hand, you will dramatically improve the odds that your next job is a permanent happy home for your practice.
===========
Guest contributor Dr. Dike Drummond, is a family physician, executive coach, and creator of the Burnout Prevention MATRIX Free Report with more than 117 different ways physicians and organizations can lower stress and prevent burnout. He provides stress management, burnout prevention, and physician wellness, and engagement coaching and consulting through his website, TheHappyMD.com.
In this article, let me show you the No. 1 mistake the vast majority of physicians make when looking for a position. When you avoid this mistake, you stand a much better chance of landing your ideal job.
Here is the physician job-search mistake in a nutshell: Do not search for a job the same way you applied to Medical School or Residency
If you do, your success in this employed position will rely purely on luck. Here is what I mean.
For most of us, the last experience we had of interviewing for a position was our application to Medical School and/or Residency. In this situation, we were basically doing anything we could to be accepted. We were saying, “Pick me, Pick me” and doing whatever it took to make it into the ranks of the chosen.
That is not what a job search is about. In fact, a healthy job search turns the tables 180 degrees – it is an awareness mind flip.
In your search for a permanent position, you want to make sure this is a place you will fit in – long term. In order to do that well, you must have an Ideal Job Description and be screening job opportunities to see if they fit your Ideal Job.
Now you are screening them ...
I have to repeat this because it is so important: You must know what you are looking for first and ask the questions required to screen them to see if they match your Ideal Job Description.
This process allows you to come home from your interview and make a high quality decision about this particular job offer. It is this simple: With your Ideal Job Description in one hand and the results of your interview in the other hand, you create a Venn diagram and measure the overlap.
Once you are able to make this comparison, you only have one decision to make: How much overlap is enough to say yes to this offer?
When you approach your physician job search in this fashion you are focused on what you want – Your Ideal Job, rather than taking any opportunity where you will be accepted. So ... what is your Ideal Job Description?
Most doctors have never created a description of their Ideal Job. We spend our time coping with the areas in our current position that are painful and anything other than “ideal.” Grab a pen and some paper. Imagine you have a Magic Wand in your hand ... you wave it and ... POOF, there’s your Dream Job in all of its glory.

Write down all the characteristics of your Ideal Job in as much detail as possible.
Here are some of the questions you will want to answer:
• What do you want to be doing - what kinds of patients and cases?
• In what setting?
• For how many hours a week?
• For what pay and benefits?
• In how big of a group?
• Where – in what area of what country?
• With what group culture and work environment?
• What are the characteristics you want in your boss?
• List all the pertinent positives and negatives.
• BOTH the things you want AND the things you want to make sure are NOT there.
This is a living document. You will add to it and subtract from it over time as you get more and more clear.
===========
Power Tip #1:
Write it down in ink on paper. Keep your Ideal Job Description in a folder with a nice label in a place so you will see it weekly. You will use this description in both your job search and in continuously improving any position you ultimately take.
You are taking something that exists only in your imagination and beginning the process of turning it into reality. The move from thought to physical pen strokes on physical paper is step No. 1. And I know this is “old school.” Try it for yourself.
Power Tip #2:
Write it down, even if you feel it is something that is “impossible.” Write it down anyway. It is a goal to shoot for that will shape your decision in a healthy way. There is no job that is a 100% overlap with your ideal. This does NOT mean you can’t aim in that direction.
Note: There are some specialties where the job market is so tight that you must still work hard to get accepted – radiology comes immediately to mind. This process works best in specialties that are in high demand at this time – especially Family Practice and all other forms of primary care.
Creating your Ideal Job Description and using it to drive your job search is Step No. 1 in getting the position you really want. In a future column, I will give you a set of questions you can ask in your job interview that will give you a clear read on the group’s culture, decision-making style and the quality of your immediate supervisor. With this information in hand, you will dramatically improve the odds that your next job is a permanent happy home for your practice.
===========
Guest contributor Dr. Dike Drummond, is a family physician, executive coach, and creator of the Burnout Prevention MATRIX Free Report with more than 117 different ways physicians and organizations can lower stress and prevent burnout. He provides stress management, burnout prevention, and physician wellness, and engagement coaching and consulting through his website, TheHappyMD.com.
Care your way to LOS solutions
High-quality care, optimal length of stay (LOS), patient satisfaction, cost-effectiveness – all part of the hospitalists’ creed, our raison d’être. But with these exist national, as well as local imperatives, some of which carry penalties and/or rewards. Public and private organizations devote a huge amount of resources into setting higher and higher bars of excellence for physicians. Individual hospitals adapt and tweak the methods of other centers that have outstanding track records in hopes they, too, may enjoy similar success. Yet, at the end of the day, we are the foot soldiers.
Insurers should not mandate the care we provide. Government should not have to tell us what is acceptable practice and what is not. And hospital administrators – God bless them – should not have to stab blindly in the dark for solutions to the problems that plague their individual institutions. After all, we physicians are at the patients’ bedsides. We talk to them and their families, consult effective and efficient specialists, write orders to take care of them, and ultimately discharge them to their next phase in care.
There is a tremendous amount of low-hanging fruit we easily could seize upon to make our hospitals run more smoothly and make our patients much happier (though the processes and procedures that make one institution ineffective may not plague the next).
For instance, many hospitals have a peak time for admissions, as well as for discharges, and these two times frequently do not coincide. As a result, there may be a backlog of patients in the emergency department (ED) awaiting a clean bed. Invariably, meanwhile, there are patients pacing the halls anxiously waiting for the doctor to arrive to discharge them. But if that doctor is busy seeing a new or very sick patient, that discharge may just have to wait, sometimes for several hours. Here, I have learned to try to look for opportunities instead of focusing on obstacles.
If I anticipate that a patient will be discharged the following day, I try prepare the discharge summary and patient instruction sheet, and to write the prescriptions a day in advance (when time permits). That way, on the following day, instead of devoting 45 minutes to reviewing the records of a lengthy hospital stay, I can simply check on the patient to confirm that she has no new problems and that her examination is stable. Within seconds, I can type in a discharge order and move along to the next patient. Even in the midst of a very busy day, I can typically work in this type of visit fairly early.
On the other hand, if the same patient is likely to be discharged the day after I leave the service, the same preparation by me can save my partner a great deal of time the next day. If everything is already done except the official discharge order, she, too, can likely discharge the patient early in the day, instead of late in the evening after she learns the entire service. (Who likes going home in the dark anyway?)
The patient is happier. The administration is happier to have more beds freed up earlier. The little old lady in the ED with a comminuted hip fracture will get a nice warm bed quicker, and the rounder is less stressed. Everyone wins!
Listening to our patients’ desires, not just their needs can also go a long way in patient satisfaction.
I recently had a patient who was visiting from the other side of the country who, unfortunately, wound up in our ED for cellulitis. She was part of a historical group from California who had traveled to the Washington, D.C., area to attend a national function. The event was to culminate in a banquet that evening – a banquet that she was going to miss. When I saw her, she acknowledged she was getting better on the intravenous vancomycin that was started in the ED the night before, and though the line of demarcation drawn by my partner clearly showed her infection was improving, she still had mild-moderate cellulitis. Her history of methicillin-resistant Staphylococcus aureus (MRSA) made me uncomfortable discharging her on a regimen that would “probably” cover MRSA, and we all know that linezolid (Zyvox) can be incredibly expensive if not on a patient’s formulary. There we were at 5 p.m. on a Saturday. Who would be reachable for a prior authorization?
As I looked down at her sad face and saw the disappointment in her eyes, I had to do something! She was in the area for a great cause; the hospitalization was an unexpected nuisance that threatened to destroy her entire trip. The solution was simple. I called her pharmacist in California and found out that her copay for Zyvox was an affordable $30, so I could safely discharge her in time for her banquet. While that falls far short of an near-miracle that changed a life, my simple effort made a big difference for her.
The point is that when we focus on the patient’s entire needs – not just the disease that brought them to the hospital in the first place – we can create solutions to many of their problems. Sometimes it’s the finishing touches, not just the medical care, that patients remember most.
Dr. Hester is a hospitalist at Baltimore-Washington Medical Center in Glen Burnie, Md. She is the creator of the Patient Whiz, a patient-engagement app for iOS. Reach her at [email protected].
High-quality care, optimal length of stay (LOS), patient satisfaction, cost-effectiveness – all part of the hospitalists’ creed, our raison d’être. But with these exist national, as well as local imperatives, some of which carry penalties and/or rewards. Public and private organizations devote a huge amount of resources into setting higher and higher bars of excellence for physicians. Individual hospitals adapt and tweak the methods of other centers that have outstanding track records in hopes they, too, may enjoy similar success. Yet, at the end of the day, we are the foot soldiers.
Insurers should not mandate the care we provide. Government should not have to tell us what is acceptable practice and what is not. And hospital administrators – God bless them – should not have to stab blindly in the dark for solutions to the problems that plague their individual institutions. After all, we physicians are at the patients’ bedsides. We talk to them and their families, consult effective and efficient specialists, write orders to take care of them, and ultimately discharge them to their next phase in care.
There is a tremendous amount of low-hanging fruit we easily could seize upon to make our hospitals run more smoothly and make our patients much happier (though the processes and procedures that make one institution ineffective may not plague the next).
For instance, many hospitals have a peak time for admissions, as well as for discharges, and these two times frequently do not coincide. As a result, there may be a backlog of patients in the emergency department (ED) awaiting a clean bed. Invariably, meanwhile, there are patients pacing the halls anxiously waiting for the doctor to arrive to discharge them. But if that doctor is busy seeing a new or very sick patient, that discharge may just have to wait, sometimes for several hours. Here, I have learned to try to look for opportunities instead of focusing on obstacles.
If I anticipate that a patient will be discharged the following day, I try prepare the discharge summary and patient instruction sheet, and to write the prescriptions a day in advance (when time permits). That way, on the following day, instead of devoting 45 minutes to reviewing the records of a lengthy hospital stay, I can simply check on the patient to confirm that she has no new problems and that her examination is stable. Within seconds, I can type in a discharge order and move along to the next patient. Even in the midst of a very busy day, I can typically work in this type of visit fairly early.
On the other hand, if the same patient is likely to be discharged the day after I leave the service, the same preparation by me can save my partner a great deal of time the next day. If everything is already done except the official discharge order, she, too, can likely discharge the patient early in the day, instead of late in the evening after she learns the entire service. (Who likes going home in the dark anyway?)
The patient is happier. The administration is happier to have more beds freed up earlier. The little old lady in the ED with a comminuted hip fracture will get a nice warm bed quicker, and the rounder is less stressed. Everyone wins!
Listening to our patients’ desires, not just their needs can also go a long way in patient satisfaction.
I recently had a patient who was visiting from the other side of the country who, unfortunately, wound up in our ED for cellulitis. She was part of a historical group from California who had traveled to the Washington, D.C., area to attend a national function. The event was to culminate in a banquet that evening – a banquet that she was going to miss. When I saw her, she acknowledged she was getting better on the intravenous vancomycin that was started in the ED the night before, and though the line of demarcation drawn by my partner clearly showed her infection was improving, she still had mild-moderate cellulitis. Her history of methicillin-resistant Staphylococcus aureus (MRSA) made me uncomfortable discharging her on a regimen that would “probably” cover MRSA, and we all know that linezolid (Zyvox) can be incredibly expensive if not on a patient’s formulary. There we were at 5 p.m. on a Saturday. Who would be reachable for a prior authorization?
As I looked down at her sad face and saw the disappointment in her eyes, I had to do something! She was in the area for a great cause; the hospitalization was an unexpected nuisance that threatened to destroy her entire trip. The solution was simple. I called her pharmacist in California and found out that her copay for Zyvox was an affordable $30, so I could safely discharge her in time for her banquet. While that falls far short of an near-miracle that changed a life, my simple effort made a big difference for her.
The point is that when we focus on the patient’s entire needs – not just the disease that brought them to the hospital in the first place – we can create solutions to many of their problems. Sometimes it’s the finishing touches, not just the medical care, that patients remember most.
Dr. Hester is a hospitalist at Baltimore-Washington Medical Center in Glen Burnie, Md. She is the creator of the Patient Whiz, a patient-engagement app for iOS. Reach her at [email protected].
High-quality care, optimal length of stay (LOS), patient satisfaction, cost-effectiveness – all part of the hospitalists’ creed, our raison d’être. But with these exist national, as well as local imperatives, some of which carry penalties and/or rewards. Public and private organizations devote a huge amount of resources into setting higher and higher bars of excellence for physicians. Individual hospitals adapt and tweak the methods of other centers that have outstanding track records in hopes they, too, may enjoy similar success. Yet, at the end of the day, we are the foot soldiers.
Insurers should not mandate the care we provide. Government should not have to tell us what is acceptable practice and what is not. And hospital administrators – God bless them – should not have to stab blindly in the dark for solutions to the problems that plague their individual institutions. After all, we physicians are at the patients’ bedsides. We talk to them and their families, consult effective and efficient specialists, write orders to take care of them, and ultimately discharge them to their next phase in care.
There is a tremendous amount of low-hanging fruit we easily could seize upon to make our hospitals run more smoothly and make our patients much happier (though the processes and procedures that make one institution ineffective may not plague the next).
For instance, many hospitals have a peak time for admissions, as well as for discharges, and these two times frequently do not coincide. As a result, there may be a backlog of patients in the emergency department (ED) awaiting a clean bed. Invariably, meanwhile, there are patients pacing the halls anxiously waiting for the doctor to arrive to discharge them. But if that doctor is busy seeing a new or very sick patient, that discharge may just have to wait, sometimes for several hours. Here, I have learned to try to look for opportunities instead of focusing on obstacles.
If I anticipate that a patient will be discharged the following day, I try prepare the discharge summary and patient instruction sheet, and to write the prescriptions a day in advance (when time permits). That way, on the following day, instead of devoting 45 minutes to reviewing the records of a lengthy hospital stay, I can simply check on the patient to confirm that she has no new problems and that her examination is stable. Within seconds, I can type in a discharge order and move along to the next patient. Even in the midst of a very busy day, I can typically work in this type of visit fairly early.
On the other hand, if the same patient is likely to be discharged the day after I leave the service, the same preparation by me can save my partner a great deal of time the next day. If everything is already done except the official discharge order, she, too, can likely discharge the patient early in the day, instead of late in the evening after she learns the entire service. (Who likes going home in the dark anyway?)
The patient is happier. The administration is happier to have more beds freed up earlier. The little old lady in the ED with a comminuted hip fracture will get a nice warm bed quicker, and the rounder is less stressed. Everyone wins!
Listening to our patients’ desires, not just their needs can also go a long way in patient satisfaction.
I recently had a patient who was visiting from the other side of the country who, unfortunately, wound up in our ED for cellulitis. She was part of a historical group from California who had traveled to the Washington, D.C., area to attend a national function. The event was to culminate in a banquet that evening – a banquet that she was going to miss. When I saw her, she acknowledged she was getting better on the intravenous vancomycin that was started in the ED the night before, and though the line of demarcation drawn by my partner clearly showed her infection was improving, she still had mild-moderate cellulitis. Her history of methicillin-resistant Staphylococcus aureus (MRSA) made me uncomfortable discharging her on a regimen that would “probably” cover MRSA, and we all know that linezolid (Zyvox) can be incredibly expensive if not on a patient’s formulary. There we were at 5 p.m. on a Saturday. Who would be reachable for a prior authorization?
As I looked down at her sad face and saw the disappointment in her eyes, I had to do something! She was in the area for a great cause; the hospitalization was an unexpected nuisance that threatened to destroy her entire trip. The solution was simple. I called her pharmacist in California and found out that her copay for Zyvox was an affordable $30, so I could safely discharge her in time for her banquet. While that falls far short of an near-miracle that changed a life, my simple effort made a big difference for her.
The point is that when we focus on the patient’s entire needs – not just the disease that brought them to the hospital in the first place – we can create solutions to many of their problems. Sometimes it’s the finishing touches, not just the medical care, that patients remember most.
Dr. Hester is a hospitalist at Baltimore-Washington Medical Center in Glen Burnie, Md. She is the creator of the Patient Whiz, a patient-engagement app for iOS. Reach her at [email protected].
Honey
Honeybees (Apis mellifera, A. cerana, A. dorsata, A. floria, A. andreniformis, A. koschevnikov, and A. laborisa) play a key role in propagating numerous plants, flower nectar, and flower pollen as well as in pollinating approximately one-third of common agricultural crops, including fruits, vegetables, nuts, and seeds (Time magazine; Proc. Biol. Sci. 2007;274[1608]:303-13). Indeed, the honeybee is the lone insect that produces food regularly consumed by human beings (Am. J. Ther. 2014;21:304-23). Honey, which contains more than 180 compounds, is produced by honeybees from flower nectar. This sweet food product is supersaturated in sugar, and also contains phenolic acids, flavonoids, ascorbic acid, alpha-tocopherol, carotenoids, the enzymes glucose oxidase and catalase, organic and amino acids, and proteins (J. Food Sci. 2008;73:R117-24). Honey has been used since ancient times in Ayurvedic medicine to treat diabetes and has long been used to treat infected wounds (Ayu 2012;33:178-82; Clin. Infect. Dis. 2009;49:1541-9). Currently, honey is used in Ayurvedic medicine to treat acne, and it is incorporated in various cosmetic formulations such as facial washes, skin moisturizers, and hair conditioners (Ayu 2012;33:178-82).
History
For at least 2,700 years, traditional medical practice has included the use of topically applied honey for various conditions, with many modern researchers retrospectively attributing this usage to the antibacterial activity of honey (Am. J. Ther. 2014;21:304-23; Clin. Infect. Dis. 2008;46:1677-82). Honey served as a potent anti-inflammatory and antibacterial agent in folk remedies in ancient Egypt, Greece, and Rome, with written references to the medical application of bee products dating back to ancientEgypt, India, and China (Am. J. Ther. 2014;21:304-23; Cancer Res. 1993;53:1255-61; Evid. Based Complement. Alternat. Med. 2013;2013:697390)). For more than 4,000 years, honey has been used in Ayurvedic medicine, and its use has been traced to the Xin dynasty in China (Am. J. Ther. 2014;21:304-23). The antibacterial characteristics of honey were first reported in 1892 (IUBMB Life 2012;64:48-55). Russia and Germany used honey for wound treatment through World War I. The traditional medical application of honey began to subside with the advent of antibiotics in the 1940s(Burns 2013; 39:1514-25; Int. J. Clin. Pract. 2007;61:1705-7).
Chemistry
Myriad biological functions are associated with honey (antibacterial, antioxidant, antitumor, anti-inflammatory, antibrowning, and antiviral) and ascribed mainly to its constituent phenolic compounds, such as flavonoids, including chrysin (J. Food Sci. 2008;73:R117-24). Indeed, medical grade honeys such as manuka honey (a monofloral honey derived from Leptospermum scoparium, a member of the Myrtaceae family, native to New Zealand) and Medihoney® (a standardized mix of Australian and New Zealand honeys) are rich in flavonoids (Int. J. Clin. Pract. 2007;61:1705-7;J. Int. Acad. Periodontol. 2004;6:63-7; Evid. Based Complement. Alternat. Med. 2009;6:165-73;J. Agric. Food Chem. 2012;60:7229-37). Honey has a pH ranging from 3.2 to 4.5 and an acidity level that stymies the growth of many microorganisms (Burns 2013;39:1514-25; J. Clin. Nurs. 2008;17:2604-23; Nurs. Times. 2006;102:40-2; Br. J. Community Nurs. 2004;Suppl:S21-7 ).
Antibacterial activity
In 2008, Kwakman et al. found that within 24 hours, 10%-40% (vol/vol) medical grade honey (Revamil) destroyed antibiotic-susceptible and antibiotic-resistant isolates of Staphylococcus aureus,S. epidermidis, Enterococcus faecium, Escherichia coli, Pseudomonas aeruginosa, Enterobacter cloacae, and Klebsiella oxytoca. After 2 days of honey application, they also observed a 100-fold decrease in forearm skin colonization in healthy volunteers, with the number of positive skin cultures declining by 76%. The researchers concluded that Revamil exhibits significant potential to prevent or treat infections, including those spawned by multidrug-resistant bacteria (Clin. Infect. Dis. 2008;46:1677-82). Honey has been demonstrated to be clinically effective in treating several kinds of wound infections, reducing skin colonization of multiple bacteria, including methicillin-resistant S. aureus (Clin. Infect. Dis. 2008;46:1677-82) and enhancing wound healing, without provoking adverse effects ( Clin. Infect. Dis. 2009;49:1541-9). Manuka honey and Medihoney are the main forms of medical grade honey used in clinical practice. Nonmedical grade honey may contain viable bacterial spores (including clostridia), and manifest less predictable antibacterial properties (Clin. Infect. Dis. 2009;49:1541-9).
Honey is used in over-the-counter products as a moisturizing agent and in hair-conditioning products based on its strong humectant properties. It is also used in home remedies to treat burns, wounds, eczema, and dermatitis, especially in Asia (Ayu 2012;33:178-8).
Seborrheic dermatitis/dandruff
In 2001, Al-Waili assessed the potential of topically applied crude honey (90% honey diluted in warm water) to treat chronic seborrheic dermatitis of the scalp, face, and chest in 30 patients (20 males and 10 females, aged 15-60 years). Over the initial 4 weeks of treatment, honey was gently rubbed onto lesions every other day for 2-3 minutes at a time, with the ointment left on for 3 hours before gentle warm-water rinsing. Then, in a 6-month prophylactic phase, the participants were divided into a once-weekly treatment group and a control group. Skin lesions healed completely within 2 weeks in the treatment group, after significant reductions in itching and scaling in just the first week. Subjective improvements in hair loss were also reported. Relapse was observed in 12 of the 15 subjects in the control group within 2-4 months of therapy cessation and none in the treatment group. The author concluded that weekly use of crude honey significantly improves seborrheic dermatitis symptoms and related hair loss (Eur. J. Med. Res. 2001;6:306-8).
Wound healing
In February 2013, Jull published a review of 25 randomized and quasirandomized trials evaluating honey in the treatment of acute or chronic wounds, finding that honey might delay healing in partial- and full-thickness burns, compared with early excision and grafting, but it does not significantly enhance healing of chronic venous leg ulcers. They suggested that while honey may prove to be more effective than some conventional dressings for such ulcers, evidence is currently insufficient to support this claim ( Cochrane Database Syst. Rev. 2013;2:CD005083). Later that year, Vandamme et al. identified 55 studies in a literature review suggesting that honey stimulates healing of burns, ulcers, and other wounds. They also found, despite some methodologic concerns, that honey exerts antibacterial activity in burn treatment and deodorizing, debridement, anti-inflammatory, and analgesic activity ( Burns 2013;39:1514-25).
Conclusion
Honey has a long history of traditional medicinal use and has been found to display significant biologic activity, including antibacterial, antioxidant, antitumor, anti-inflammatory, antibrowning, and antiviral. The antibacterial properties of honey are particularly compelling. While more research, in the form of randomized, controlled trials, is needed prior to incorporating bee products into the dermatologic armamentarium as first-line therapies, the potential of honey usage for skin care is promising.
Dr. Baumann is chief executive officer of the Baumann Cosmetic & Research Institute in Miami Beach. She founded the cosmetic dermatology center at the University of Miami in 1997. Dr. Baumann wrote the textbook “Cosmetic Dermatology: Principles and Practice” (McGraw-Hill, April 2002), and a book for consumers, “The Skin Type Solution” (Bantam, 2006). She has contributed to the Cosmeceutical Critique column in Skin & Allergy News since January 2001. Dr. Baumann has received funding for clinical grants from Allergan, Aveeno, Avon Products, Galderma, Mary Kay, Medicis Pharmaceuticals, Neutrogena, Philosophy, Stiefel, Topix Pharmaceuticals, and Unilever.
Honeybees (Apis mellifera, A. cerana, A. dorsata, A. floria, A. andreniformis, A. koschevnikov, and A. laborisa) play a key role in propagating numerous plants, flower nectar, and flower pollen as well as in pollinating approximately one-third of common agricultural crops, including fruits, vegetables, nuts, and seeds (Time magazine; Proc. Biol. Sci. 2007;274[1608]:303-13). Indeed, the honeybee is the lone insect that produces food regularly consumed by human beings (Am. J. Ther. 2014;21:304-23). Honey, which contains more than 180 compounds, is produced by honeybees from flower nectar. This sweet food product is supersaturated in sugar, and also contains phenolic acids, flavonoids, ascorbic acid, alpha-tocopherol, carotenoids, the enzymes glucose oxidase and catalase, organic and amino acids, and proteins (J. Food Sci. 2008;73:R117-24). Honey has been used since ancient times in Ayurvedic medicine to treat diabetes and has long been used to treat infected wounds (Ayu 2012;33:178-82; Clin. Infect. Dis. 2009;49:1541-9). Currently, honey is used in Ayurvedic medicine to treat acne, and it is incorporated in various cosmetic formulations such as facial washes, skin moisturizers, and hair conditioners (Ayu 2012;33:178-82).
History
For at least 2,700 years, traditional medical practice has included the use of topically applied honey for various conditions, with many modern researchers retrospectively attributing this usage to the antibacterial activity of honey (Am. J. Ther. 2014;21:304-23; Clin. Infect. Dis. 2008;46:1677-82). Honey served as a potent anti-inflammatory and antibacterial agent in folk remedies in ancient Egypt, Greece, and Rome, with written references to the medical application of bee products dating back to ancientEgypt, India, and China (Am. J. Ther. 2014;21:304-23; Cancer Res. 1993;53:1255-61; Evid. Based Complement. Alternat. Med. 2013;2013:697390)). For more than 4,000 years, honey has been used in Ayurvedic medicine, and its use has been traced to the Xin dynasty in China (Am. J. Ther. 2014;21:304-23). The antibacterial characteristics of honey were first reported in 1892 (IUBMB Life 2012;64:48-55). Russia and Germany used honey for wound treatment through World War I. The traditional medical application of honey began to subside with the advent of antibiotics in the 1940s(Burns 2013; 39:1514-25; Int. J. Clin. Pract. 2007;61:1705-7).
Chemistry
Myriad biological functions are associated with honey (antibacterial, antioxidant, antitumor, anti-inflammatory, antibrowning, and antiviral) and ascribed mainly to its constituent phenolic compounds, such as flavonoids, including chrysin (J. Food Sci. 2008;73:R117-24). Indeed, medical grade honeys such as manuka honey (a monofloral honey derived from Leptospermum scoparium, a member of the Myrtaceae family, native to New Zealand) and Medihoney® (a standardized mix of Australian and New Zealand honeys) are rich in flavonoids (Int. J. Clin. Pract. 2007;61:1705-7;J. Int. Acad. Periodontol. 2004;6:63-7; Evid. Based Complement. Alternat. Med. 2009;6:165-73;J. Agric. Food Chem. 2012;60:7229-37). Honey has a pH ranging from 3.2 to 4.5 and an acidity level that stymies the growth of many microorganisms (Burns 2013;39:1514-25; J. Clin. Nurs. 2008;17:2604-23; Nurs. Times. 2006;102:40-2; Br. J. Community Nurs. 2004;Suppl:S21-7 ).
Antibacterial activity
In 2008, Kwakman et al. found that within 24 hours, 10%-40% (vol/vol) medical grade honey (Revamil) destroyed antibiotic-susceptible and antibiotic-resistant isolates of Staphylococcus aureus,S. epidermidis, Enterococcus faecium, Escherichia coli, Pseudomonas aeruginosa, Enterobacter cloacae, and Klebsiella oxytoca. After 2 days of honey application, they also observed a 100-fold decrease in forearm skin colonization in healthy volunteers, with the number of positive skin cultures declining by 76%. The researchers concluded that Revamil exhibits significant potential to prevent or treat infections, including those spawned by multidrug-resistant bacteria (Clin. Infect. Dis. 2008;46:1677-82). Honey has been demonstrated to be clinically effective in treating several kinds of wound infections, reducing skin colonization of multiple bacteria, including methicillin-resistant S. aureus (Clin. Infect. Dis. 2008;46:1677-82) and enhancing wound healing, without provoking adverse effects ( Clin. Infect. Dis. 2009;49:1541-9). Manuka honey and Medihoney are the main forms of medical grade honey used in clinical practice. Nonmedical grade honey may contain viable bacterial spores (including clostridia), and manifest less predictable antibacterial properties (Clin. Infect. Dis. 2009;49:1541-9).
Honey is used in over-the-counter products as a moisturizing agent and in hair-conditioning products based on its strong humectant properties. It is also used in home remedies to treat burns, wounds, eczema, and dermatitis, especially in Asia (Ayu 2012;33:178-8).
Seborrheic dermatitis/dandruff
In 2001, Al-Waili assessed the potential of topically applied crude honey (90% honey diluted in warm water) to treat chronic seborrheic dermatitis of the scalp, face, and chest in 30 patients (20 males and 10 females, aged 15-60 years). Over the initial 4 weeks of treatment, honey was gently rubbed onto lesions every other day for 2-3 minutes at a time, with the ointment left on for 3 hours before gentle warm-water rinsing. Then, in a 6-month prophylactic phase, the participants were divided into a once-weekly treatment group and a control group. Skin lesions healed completely within 2 weeks in the treatment group, after significant reductions in itching and scaling in just the first week. Subjective improvements in hair loss were also reported. Relapse was observed in 12 of the 15 subjects in the control group within 2-4 months of therapy cessation and none in the treatment group. The author concluded that weekly use of crude honey significantly improves seborrheic dermatitis symptoms and related hair loss (Eur. J. Med. Res. 2001;6:306-8).
Wound healing
In February 2013, Jull published a review of 25 randomized and quasirandomized trials evaluating honey in the treatment of acute or chronic wounds, finding that honey might delay healing in partial- and full-thickness burns, compared with early excision and grafting, but it does not significantly enhance healing of chronic venous leg ulcers. They suggested that while honey may prove to be more effective than some conventional dressings for such ulcers, evidence is currently insufficient to support this claim ( Cochrane Database Syst. Rev. 2013;2:CD005083). Later that year, Vandamme et al. identified 55 studies in a literature review suggesting that honey stimulates healing of burns, ulcers, and other wounds. They also found, despite some methodologic concerns, that honey exerts antibacterial activity in burn treatment and deodorizing, debridement, anti-inflammatory, and analgesic activity ( Burns 2013;39:1514-25).
Conclusion
Honey has a long history of traditional medicinal use and has been found to display significant biologic activity, including antibacterial, antioxidant, antitumor, anti-inflammatory, antibrowning, and antiviral. The antibacterial properties of honey are particularly compelling. While more research, in the form of randomized, controlled trials, is needed prior to incorporating bee products into the dermatologic armamentarium as first-line therapies, the potential of honey usage for skin care is promising.
Dr. Baumann is chief executive officer of the Baumann Cosmetic & Research Institute in Miami Beach. She founded the cosmetic dermatology center at the University of Miami in 1997. Dr. Baumann wrote the textbook “Cosmetic Dermatology: Principles and Practice” (McGraw-Hill, April 2002), and a book for consumers, “The Skin Type Solution” (Bantam, 2006). She has contributed to the Cosmeceutical Critique column in Skin & Allergy News since January 2001. Dr. Baumann has received funding for clinical grants from Allergan, Aveeno, Avon Products, Galderma, Mary Kay, Medicis Pharmaceuticals, Neutrogena, Philosophy, Stiefel, Topix Pharmaceuticals, and Unilever.
Honeybees (Apis mellifera, A. cerana, A. dorsata, A. floria, A. andreniformis, A. koschevnikov, and A. laborisa) play a key role in propagating numerous plants, flower nectar, and flower pollen as well as in pollinating approximately one-third of common agricultural crops, including fruits, vegetables, nuts, and seeds (Time magazine; Proc. Biol. Sci. 2007;274[1608]:303-13). Indeed, the honeybee is the lone insect that produces food regularly consumed by human beings (Am. J. Ther. 2014;21:304-23). Honey, which contains more than 180 compounds, is produced by honeybees from flower nectar. This sweet food product is supersaturated in sugar, and also contains phenolic acids, flavonoids, ascorbic acid, alpha-tocopherol, carotenoids, the enzymes glucose oxidase and catalase, organic and amino acids, and proteins (J. Food Sci. 2008;73:R117-24). Honey has been used since ancient times in Ayurvedic medicine to treat diabetes and has long been used to treat infected wounds (Ayu 2012;33:178-82; Clin. Infect. Dis. 2009;49:1541-9). Currently, honey is used in Ayurvedic medicine to treat acne, and it is incorporated in various cosmetic formulations such as facial washes, skin moisturizers, and hair conditioners (Ayu 2012;33:178-82).
History
For at least 2,700 years, traditional medical practice has included the use of topically applied honey for various conditions, with many modern researchers retrospectively attributing this usage to the antibacterial activity of honey (Am. J. Ther. 2014;21:304-23; Clin. Infect. Dis. 2008;46:1677-82). Honey served as a potent anti-inflammatory and antibacterial agent in folk remedies in ancient Egypt, Greece, and Rome, with written references to the medical application of bee products dating back to ancientEgypt, India, and China (Am. J. Ther. 2014;21:304-23; Cancer Res. 1993;53:1255-61; Evid. Based Complement. Alternat. Med. 2013;2013:697390)). For more than 4,000 years, honey has been used in Ayurvedic medicine, and its use has been traced to the Xin dynasty in China (Am. J. Ther. 2014;21:304-23). The antibacterial characteristics of honey were first reported in 1892 (IUBMB Life 2012;64:48-55). Russia and Germany used honey for wound treatment through World War I. The traditional medical application of honey began to subside with the advent of antibiotics in the 1940s(Burns 2013; 39:1514-25; Int. J. Clin. Pract. 2007;61:1705-7).
Chemistry
Myriad biological functions are associated with honey (antibacterial, antioxidant, antitumor, anti-inflammatory, antibrowning, and antiviral) and ascribed mainly to its constituent phenolic compounds, such as flavonoids, including chrysin (J. Food Sci. 2008;73:R117-24). Indeed, medical grade honeys such as manuka honey (a monofloral honey derived from Leptospermum scoparium, a member of the Myrtaceae family, native to New Zealand) and Medihoney® (a standardized mix of Australian and New Zealand honeys) are rich in flavonoids (Int. J. Clin. Pract. 2007;61:1705-7;J. Int. Acad. Periodontol. 2004;6:63-7; Evid. Based Complement. Alternat. Med. 2009;6:165-73;J. Agric. Food Chem. 2012;60:7229-37). Honey has a pH ranging from 3.2 to 4.5 and an acidity level that stymies the growth of many microorganisms (Burns 2013;39:1514-25; J. Clin. Nurs. 2008;17:2604-23; Nurs. Times. 2006;102:40-2; Br. J. Community Nurs. 2004;Suppl:S21-7 ).
Antibacterial activity
In 2008, Kwakman et al. found that within 24 hours, 10%-40% (vol/vol) medical grade honey (Revamil) destroyed antibiotic-susceptible and antibiotic-resistant isolates of Staphylococcus aureus,S. epidermidis, Enterococcus faecium, Escherichia coli, Pseudomonas aeruginosa, Enterobacter cloacae, and Klebsiella oxytoca. After 2 days of honey application, they also observed a 100-fold decrease in forearm skin colonization in healthy volunteers, with the number of positive skin cultures declining by 76%. The researchers concluded that Revamil exhibits significant potential to prevent or treat infections, including those spawned by multidrug-resistant bacteria (Clin. Infect. Dis. 2008;46:1677-82). Honey has been demonstrated to be clinically effective in treating several kinds of wound infections, reducing skin colonization of multiple bacteria, including methicillin-resistant S. aureus (Clin. Infect. Dis. 2008;46:1677-82) and enhancing wound healing, without provoking adverse effects ( Clin. Infect. Dis. 2009;49:1541-9). Manuka honey and Medihoney are the main forms of medical grade honey used in clinical practice. Nonmedical grade honey may contain viable bacterial spores (including clostridia), and manifest less predictable antibacterial properties (Clin. Infect. Dis. 2009;49:1541-9).
Honey is used in over-the-counter products as a moisturizing agent and in hair-conditioning products based on its strong humectant properties. It is also used in home remedies to treat burns, wounds, eczema, and dermatitis, especially in Asia (Ayu 2012;33:178-8).
Seborrheic dermatitis/dandruff
In 2001, Al-Waili assessed the potential of topically applied crude honey (90% honey diluted in warm water) to treat chronic seborrheic dermatitis of the scalp, face, and chest in 30 patients (20 males and 10 females, aged 15-60 years). Over the initial 4 weeks of treatment, honey was gently rubbed onto lesions every other day for 2-3 minutes at a time, with the ointment left on for 3 hours before gentle warm-water rinsing. Then, in a 6-month prophylactic phase, the participants were divided into a once-weekly treatment group and a control group. Skin lesions healed completely within 2 weeks in the treatment group, after significant reductions in itching and scaling in just the first week. Subjective improvements in hair loss were also reported. Relapse was observed in 12 of the 15 subjects in the control group within 2-4 months of therapy cessation and none in the treatment group. The author concluded that weekly use of crude honey significantly improves seborrheic dermatitis symptoms and related hair loss (Eur. J. Med. Res. 2001;6:306-8).
Wound healing
In February 2013, Jull published a review of 25 randomized and quasirandomized trials evaluating honey in the treatment of acute or chronic wounds, finding that honey might delay healing in partial- and full-thickness burns, compared with early excision and grafting, but it does not significantly enhance healing of chronic venous leg ulcers. They suggested that while honey may prove to be more effective than some conventional dressings for such ulcers, evidence is currently insufficient to support this claim ( Cochrane Database Syst. Rev. 2013;2:CD005083). Later that year, Vandamme et al. identified 55 studies in a literature review suggesting that honey stimulates healing of burns, ulcers, and other wounds. They also found, despite some methodologic concerns, that honey exerts antibacterial activity in burn treatment and deodorizing, debridement, anti-inflammatory, and analgesic activity ( Burns 2013;39:1514-25).
Conclusion
Honey has a long history of traditional medicinal use and has been found to display significant biologic activity, including antibacterial, antioxidant, antitumor, anti-inflammatory, antibrowning, and antiviral. The antibacterial properties of honey are particularly compelling. While more research, in the form of randomized, controlled trials, is needed prior to incorporating bee products into the dermatologic armamentarium as first-line therapies, the potential of honey usage for skin care is promising.
Dr. Baumann is chief executive officer of the Baumann Cosmetic & Research Institute in Miami Beach. She founded the cosmetic dermatology center at the University of Miami in 1997. Dr. Baumann wrote the textbook “Cosmetic Dermatology: Principles and Practice” (McGraw-Hill, April 2002), and a book for consumers, “The Skin Type Solution” (Bantam, 2006). She has contributed to the Cosmeceutical Critique column in Skin & Allergy News since January 2001. Dr. Baumann has received funding for clinical grants from Allergan, Aveeno, Avon Products, Galderma, Mary Kay, Medicis Pharmaceuticals, Neutrogena, Philosophy, Stiefel, Topix Pharmaceuticals, and Unilever.
E-mailing patients
I’ve never lived in a world without e-mail. No, I’m not one of those millennial kids; e-mail has been around for a long time. Sending messages between computers dates to the 1960s, but most people consider 1971 to be the birth of e-mail. That’s when Ray Tomlinson added the @ symbol to separate users’ names from their e-mail addresses.
Today, e-mail is ubiquitous. You can e-mail your mother, your colleagues, or your cable company. You can even e-mail the president of the United States. Other than the pope and most physicians, there aren’t many people you cannot e-mail. (Although, interestingly, you can reach His Holiness on Twitter @Pontifex.)
We physicians have historically had a few good reasons to avoid e-mailing patients, but many of those objections are unwarranted. As part the meaningful use EHR incentive program from the Centers for Medicare & Medicaid Services, secure messaging will now be required to be eligible for rewards. Although many physicians cite security as a concern, most electronic medical record systems now have patient portals that allow for secure, safe messaging. Encroachment into private time, however, is still a concern for many physicians.
At Kaiser Permanente (KP), we’ve been using secure e-mails with our patients for more than 5 years. When we started, I had some of the same concerns as most doctors: When am I going to have time to do this? What types of questions will patients send? As it turns out, the system has been wildly popular for patients. In 2013 alone, we replied to more than 14 million patient messages. We encourage our patients to use e-mail to stay connected with us, because it leads to improved patient experiences and improved outcomes.
Managing e-mail in-boxes is difficult work, and we KP physicians constantly try to find ways to be more efficient. E-mail does sometimes encroach on my personal time, but I’ve discovered that’s okay. As it turns out, e-mail encroaches on my entrepreneurial brother’s personal time, my financial planner’s personal time, and my plumber’s personal time. Being always connected is a modern luxury and a curse. It’s also part of being a professional.
Here are some steps I’ve taken to manage my patient e-mails. First, I always remember that this electronic message is connected to a real person with real worry. Second, I remember how appreciative patients are to get a message from their doctor. E-mail a patient after 8 p.m., and they will never forget you. Third, clearly delineate time to take care of business. It never feels burdensome in part because I am in control. I choose to e-mail patients not because I have to but because I’m that doctor and it makes me feel good.
This weekend, for example, I did patient messages in a Jackson Hole, Wyo., coffee shop while on vacation. Just as I opened my computer, I noticed a young guy in a fleece jacket next to me checking his e-mail while his wife and two kids enjoyed muffins and hot cocoa. While I was waiting for my wife, Susan, to order our lattes, I overheard him make a call to his office: “Yes, I’m out, but why don’t you e-mail me that and I’ll get right back to you.”
I’m right with you, buddy, I think. I use my token and the wifi there in Wyoming to access my patient e-mails. There are only five. The messages are like most I receive: “I have a new spot,” or “The cream you gave me isn’t working,” or “My acne is better, so should I reduce the spironolactone?” I hammer replies out in 10 minutes.
My wife returns with lattes and opens the local paper while I review 14 biopsy results from 2 days ago. For most of them, I use a template and the secure e-mail to send patients their results. I then send a few notes to some patients, advising them to follow up with me for excisional surgeries.
The work I was doing was not additive; the questions my patients sent would have had to be addressed at some time. In fact, if they had called, then they would have left a message with a nurse who would have sent a message to me, which I would have had to reply to, and then send the message back to the nurse who would have to reply to the patient.
Despite our love/hate relationship with it, e-mail has been one of the great innovations of the 20th century, and it is the primary form of communication in the business world. According to one study, more than 100 billion business e-mails were sent and received every day in 2013. Yet, fewer than one-third of physicians use e-mail to communicate with their patients.Personally, I have found patients to be generally understanding, courteous, and appreciative of e-mail. Of course, there are a few who don’t follow good etiquette. (One of my primary care colleagues relates a story of a patient who e-mailed her every time she had a bowel movement. Gastroenteritis can significantly add to e-mail burden, apparently.)
There’s no doubt that e-mail will soon become the primary way to communicate with patients. Based on our experience at KP, this will ultimately be to the benefit of both doctors and patients. A June 2014 survey by Catalyst Healthcare Research showed that 93% of patients preferred to see a physician who offers e-mail communication with his or her patients. More than one-quarter of those respondents said they’d be willing to pay a $25 charge for such communication. It’s not surprising; as with all businesses, not just medicine, that patients want more channels of communication, not fewer. Fortunately for them, many of today’s medical residents are being trained to use electronic communication with patients. For instance, a 2013 study published in the Postgraduate Medical Journal found that 57% of residents used e-mail to communicate with patients.
My wife finished reading the Jackson Hole Daily newspaper and outlined our hike to Taggart Lake. And I finished answering my messages. The guy sitting next to me is still tapping away at his keyboard. I make eye contact and say, “Almost done?” “Yup,” he replies, “Better for me to just knock it out now, because I’ll just have to deal with it on Monday.” I agree.
Susan and I pack up and head for the trail, which is thankfully connection free. Let’s just hope we don’t run into any bears.
Dr. Benabio is a partner physician in the department of dermatology of the Southern California Permanente Group in San Diego, and volunteer clinical assistant professor at the University of California, San Diego. Dr. Benabio is @dermdoc on Twitter.
I’ve never lived in a world without e-mail. No, I’m not one of those millennial kids; e-mail has been around for a long time. Sending messages between computers dates to the 1960s, but most people consider 1971 to be the birth of e-mail. That’s when Ray Tomlinson added the @ symbol to separate users’ names from their e-mail addresses.
Today, e-mail is ubiquitous. You can e-mail your mother, your colleagues, or your cable company. You can even e-mail the president of the United States. Other than the pope and most physicians, there aren’t many people you cannot e-mail. (Although, interestingly, you can reach His Holiness on Twitter @Pontifex.)
We physicians have historically had a few good reasons to avoid e-mailing patients, but many of those objections are unwarranted. As part the meaningful use EHR incentive program from the Centers for Medicare & Medicaid Services, secure messaging will now be required to be eligible for rewards. Although many physicians cite security as a concern, most electronic medical record systems now have patient portals that allow for secure, safe messaging. Encroachment into private time, however, is still a concern for many physicians.
At Kaiser Permanente (KP), we’ve been using secure e-mails with our patients for more than 5 years. When we started, I had some of the same concerns as most doctors: When am I going to have time to do this? What types of questions will patients send? As it turns out, the system has been wildly popular for patients. In 2013 alone, we replied to more than 14 million patient messages. We encourage our patients to use e-mail to stay connected with us, because it leads to improved patient experiences and improved outcomes.
Managing e-mail in-boxes is difficult work, and we KP physicians constantly try to find ways to be more efficient. E-mail does sometimes encroach on my personal time, but I’ve discovered that’s okay. As it turns out, e-mail encroaches on my entrepreneurial brother’s personal time, my financial planner’s personal time, and my plumber’s personal time. Being always connected is a modern luxury and a curse. It’s also part of being a professional.
Here are some steps I’ve taken to manage my patient e-mails. First, I always remember that this electronic message is connected to a real person with real worry. Second, I remember how appreciative patients are to get a message from their doctor. E-mail a patient after 8 p.m., and they will never forget you. Third, clearly delineate time to take care of business. It never feels burdensome in part because I am in control. I choose to e-mail patients not because I have to but because I’m that doctor and it makes me feel good.
This weekend, for example, I did patient messages in a Jackson Hole, Wyo., coffee shop while on vacation. Just as I opened my computer, I noticed a young guy in a fleece jacket next to me checking his e-mail while his wife and two kids enjoyed muffins and hot cocoa. While I was waiting for my wife, Susan, to order our lattes, I overheard him make a call to his office: “Yes, I’m out, but why don’t you e-mail me that and I’ll get right back to you.”
I’m right with you, buddy, I think. I use my token and the wifi there in Wyoming to access my patient e-mails. There are only five. The messages are like most I receive: “I have a new spot,” or “The cream you gave me isn’t working,” or “My acne is better, so should I reduce the spironolactone?” I hammer replies out in 10 minutes.
My wife returns with lattes and opens the local paper while I review 14 biopsy results from 2 days ago. For most of them, I use a template and the secure e-mail to send patients their results. I then send a few notes to some patients, advising them to follow up with me for excisional surgeries.
The work I was doing was not additive; the questions my patients sent would have had to be addressed at some time. In fact, if they had called, then they would have left a message with a nurse who would have sent a message to me, which I would have had to reply to, and then send the message back to the nurse who would have to reply to the patient.
Despite our love/hate relationship with it, e-mail has been one of the great innovations of the 20th century, and it is the primary form of communication in the business world. According to one study, more than 100 billion business e-mails were sent and received every day in 2013. Yet, fewer than one-third of physicians use e-mail to communicate with their patients.Personally, I have found patients to be generally understanding, courteous, and appreciative of e-mail. Of course, there are a few who don’t follow good etiquette. (One of my primary care colleagues relates a story of a patient who e-mailed her every time she had a bowel movement. Gastroenteritis can significantly add to e-mail burden, apparently.)
There’s no doubt that e-mail will soon become the primary way to communicate with patients. Based on our experience at KP, this will ultimately be to the benefit of both doctors and patients. A June 2014 survey by Catalyst Healthcare Research showed that 93% of patients preferred to see a physician who offers e-mail communication with his or her patients. More than one-quarter of those respondents said they’d be willing to pay a $25 charge for such communication. It’s not surprising; as with all businesses, not just medicine, that patients want more channels of communication, not fewer. Fortunately for them, many of today’s medical residents are being trained to use electronic communication with patients. For instance, a 2013 study published in the Postgraduate Medical Journal found that 57% of residents used e-mail to communicate with patients.
My wife finished reading the Jackson Hole Daily newspaper and outlined our hike to Taggart Lake. And I finished answering my messages. The guy sitting next to me is still tapping away at his keyboard. I make eye contact and say, “Almost done?” “Yup,” he replies, “Better for me to just knock it out now, because I’ll just have to deal with it on Monday.” I agree.
Susan and I pack up and head for the trail, which is thankfully connection free. Let’s just hope we don’t run into any bears.
Dr. Benabio is a partner physician in the department of dermatology of the Southern California Permanente Group in San Diego, and volunteer clinical assistant professor at the University of California, San Diego. Dr. Benabio is @dermdoc on Twitter.
I’ve never lived in a world without e-mail. No, I’m not one of those millennial kids; e-mail has been around for a long time. Sending messages between computers dates to the 1960s, but most people consider 1971 to be the birth of e-mail. That’s when Ray Tomlinson added the @ symbol to separate users’ names from their e-mail addresses.
Today, e-mail is ubiquitous. You can e-mail your mother, your colleagues, or your cable company. You can even e-mail the president of the United States. Other than the pope and most physicians, there aren’t many people you cannot e-mail. (Although, interestingly, you can reach His Holiness on Twitter @Pontifex.)
We physicians have historically had a few good reasons to avoid e-mailing patients, but many of those objections are unwarranted. As part the meaningful use EHR incentive program from the Centers for Medicare & Medicaid Services, secure messaging will now be required to be eligible for rewards. Although many physicians cite security as a concern, most electronic medical record systems now have patient portals that allow for secure, safe messaging. Encroachment into private time, however, is still a concern for many physicians.
At Kaiser Permanente (KP), we’ve been using secure e-mails with our patients for more than 5 years. When we started, I had some of the same concerns as most doctors: When am I going to have time to do this? What types of questions will patients send? As it turns out, the system has been wildly popular for patients. In 2013 alone, we replied to more than 14 million patient messages. We encourage our patients to use e-mail to stay connected with us, because it leads to improved patient experiences and improved outcomes.
Managing e-mail in-boxes is difficult work, and we KP physicians constantly try to find ways to be more efficient. E-mail does sometimes encroach on my personal time, but I’ve discovered that’s okay. As it turns out, e-mail encroaches on my entrepreneurial brother’s personal time, my financial planner’s personal time, and my plumber’s personal time. Being always connected is a modern luxury and a curse. It’s also part of being a professional.
Here are some steps I’ve taken to manage my patient e-mails. First, I always remember that this electronic message is connected to a real person with real worry. Second, I remember how appreciative patients are to get a message from their doctor. E-mail a patient after 8 p.m., and they will never forget you. Third, clearly delineate time to take care of business. It never feels burdensome in part because I am in control. I choose to e-mail patients not because I have to but because I’m that doctor and it makes me feel good.
This weekend, for example, I did patient messages in a Jackson Hole, Wyo., coffee shop while on vacation. Just as I opened my computer, I noticed a young guy in a fleece jacket next to me checking his e-mail while his wife and two kids enjoyed muffins and hot cocoa. While I was waiting for my wife, Susan, to order our lattes, I overheard him make a call to his office: “Yes, I’m out, but why don’t you e-mail me that and I’ll get right back to you.”
I’m right with you, buddy, I think. I use my token and the wifi there in Wyoming to access my patient e-mails. There are only five. The messages are like most I receive: “I have a new spot,” or “The cream you gave me isn’t working,” or “My acne is better, so should I reduce the spironolactone?” I hammer replies out in 10 minutes.
My wife returns with lattes and opens the local paper while I review 14 biopsy results from 2 days ago. For most of them, I use a template and the secure e-mail to send patients their results. I then send a few notes to some patients, advising them to follow up with me for excisional surgeries.
The work I was doing was not additive; the questions my patients sent would have had to be addressed at some time. In fact, if they had called, then they would have left a message with a nurse who would have sent a message to me, which I would have had to reply to, and then send the message back to the nurse who would have to reply to the patient.
Despite our love/hate relationship with it, e-mail has been one of the great innovations of the 20th century, and it is the primary form of communication in the business world. According to one study, more than 100 billion business e-mails were sent and received every day in 2013. Yet, fewer than one-third of physicians use e-mail to communicate with their patients.Personally, I have found patients to be generally understanding, courteous, and appreciative of e-mail. Of course, there are a few who don’t follow good etiquette. (One of my primary care colleagues relates a story of a patient who e-mailed her every time she had a bowel movement. Gastroenteritis can significantly add to e-mail burden, apparently.)
There’s no doubt that e-mail will soon become the primary way to communicate with patients. Based on our experience at KP, this will ultimately be to the benefit of both doctors and patients. A June 2014 survey by Catalyst Healthcare Research showed that 93% of patients preferred to see a physician who offers e-mail communication with his or her patients. More than one-quarter of those respondents said they’d be willing to pay a $25 charge for such communication. It’s not surprising; as with all businesses, not just medicine, that patients want more channels of communication, not fewer. Fortunately for them, many of today’s medical residents are being trained to use electronic communication with patients. For instance, a 2013 study published in the Postgraduate Medical Journal found that 57% of residents used e-mail to communicate with patients.
My wife finished reading the Jackson Hole Daily newspaper and outlined our hike to Taggart Lake. And I finished answering my messages. The guy sitting next to me is still tapping away at his keyboard. I make eye contact and say, “Almost done?” “Yup,” he replies, “Better for me to just knock it out now, because I’ll just have to deal with it on Monday.” I agree.
Susan and I pack up and head for the trail, which is thankfully connection free. Let’s just hope we don’t run into any bears.
Dr. Benabio is a partner physician in the department of dermatology of the Southern California Permanente Group in San Diego, and volunteer clinical assistant professor at the University of California, San Diego. Dr. Benabio is @dermdoc on Twitter.
I Am Psyched; Are You?
For the past two centuries, disorders of behavior have been held separate and distinct from manifestations of systemic disease that are more easily characterized by the science of the day. In the 19th century, individuals with behavioral disorders were confined to psychiatric hospitals, and in the 20th century, community mental health centers were established and funded under rules that were distinct from those of the evolving system of health care in the United States. The resulting segregation of mental health from primary care has created a crisis that plays out in the national media on a daily basis. Moreover, the continuing economic impact of maintaining this separation has profound implications for the future.
Change is upon us. Seeing the handwriting on the wall isn’t the result of a delusion. It is hard to argue that mental health is not a cornerstone of an individual’s overall well-being and the foundation of health. Behavior has a profound effect on organic pathologies, and pathologies impact behavior. To separate mental health from primary care makes little sense, and it is time to recognize that mental health is an important component of primary care.
Consider the evidence. Any experienced health care practitioner recognizes the immense role that mental health plays in patient care. Simply looking at the waiting area of a community health center (CHC) provides stark evidence. The medical director for one CHC estimated that “at least 85% of the patients seen at my practice have some form of comorbid mental health and physical health chronic disease.”1 Others have suggested that half the individuals in a CHC waiting area are there primarily for some recognized or unrecognized mental health issue.2 There is no doubt that this is also the case in America’s emergency departments and other primary care clinics.
People with mental health disorders have a higher mortality rate and often die prematurely due to well understood and preventable diseases such as diabetes, hypertension, respiratory problems, and infectious disorders. One need look no further than a recent issue of JAMA to understand the impact of mental health comorbidities on diabetes. Diabetic persons with depression are poorly compliant, have poor glycemic control, and experience more diabetic complications and decreased quality of life. Moreover, the economic impact of this comorbidity is staggering when the costs of increased care, unemployment, and work disability are added to the physical toll.3
With arguments as compelling and apparent as these, why then has it been so difficult to achieve meaningful levels of integration? The barriers are many. Reimbursement, legislation, and role identities are familiar reasons that an out-of-date, inefficient system continues to be propagated. But these obstacles are beginning to crumble. Providing primary care without integrating mental health is literally caring for the body and ignoring the mind. Integration of primary and mental health is now the battle cry as systems define the medical homes of the future.
Anticipating the changing environment in health care, the Substance Abuse and Mental Health Services Administration (SAMHSA) has funded a series of studies that review the diversity of approaches to mental health services and attempt to define an optimum future framework that will bring mental health back into the domain of primary care. The results of these studies were recently published as a Rand Corporation Research Report.4
Yet even as vested parties seek to identify the best practices for this integration, it is clear that the biggest challenge relates to the workforce. The logic of integration is unimpeachable and the process already in motion (unlike most changes, this one is rapidly occurring), but the supply of qualified providers is woefully inadequate.
CHCs are the largest health care system in the US and provide the “safety net” for the country’s approximately 25 million uninsured and underinsured individuals. Over the next five years, this number will grow to more than 35 million. About 70% of CHCs presently offer mental health services in some form.1 A recent survey of CHC leaders found that their biggest fear is the tidal wave of mental health problems and their ability to adequately address the needs of these patients because of a severe shortage of properly educated providers.
Psychiatrists are rare in CHCs, and those that exist focus a majority of their time on the most acutely ill. Some centers have formed alliances with community-based mental health services, but too often patient referrals don’t happen or the patient is lost to follow-up. The complex maze of reimbursement, prescribing, and follow-up makes the continued propagation of this inefficient approach unacceptable for the future.
What is needed are clinicians who are properly educated to begin to fill the gap. As such, the workforce challenges of this integration represent a significant opportunity, especially for PAs and NPs. With the exception of physicians, who are in increasingly limited supply, there are no other health care professionals who have the capability to bridge the gap between primary care and mental health. To meet the projected workforce needs, PAs and NPs will have to make a significant commitment to gain the necessary knowledge, skills, and behaviors required to treat mental health problems.
There are a number of excellent entry-level psychiatric nurse practitioner programs that prepare NPs to provide both primary and mental health care. However, most entry-level PA programs don’t have the time to do more than skim the surface of mental health care as they prepare students to begin practice as broadly educated generalist caregivers.
Fortunately, about three years ago, the National Commission on the Certification of Physician Assistants (NCCPA) began to recognize the qualifications and promote the need for PAs with advanced skills in psychiatry and mental health. As of December 2013, almost 100 PAs had successfully received a Certificate of Advanced Qualification (CAQ) in psychiatry from the NCCPA. The nation needs more than 0.1% of all PAs with a credential that recognizes their expertise in mental health. It is time to set an aggressive goal of having 1% of all PAs with a CAQ in psychiatry within the next five years.
Any PA or NP planning their future should give serious consideration to the overwhelming demand for practitioners who can effectively link primary care and mental health. This opportunity for individuals is a current reality. But even greater is the opportunity for the professions to claim a very meaningful and needed position on the health care teams of the future.
I hope you agree. Please share your thoughts with me via [email protected].
For the past two centuries, disorders of behavior have been held separate and distinct from manifestations of systemic disease that are more easily characterized by the science of the day. In the 19th century, individuals with behavioral disorders were confined to psychiatric hospitals, and in the 20th century, community mental health centers were established and funded under rules that were distinct from those of the evolving system of health care in the United States. The resulting segregation of mental health from primary care has created a crisis that plays out in the national media on a daily basis. Moreover, the continuing economic impact of maintaining this separation has profound implications for the future.
Change is upon us. Seeing the handwriting on the wall isn’t the result of a delusion. It is hard to argue that mental health is not a cornerstone of an individual’s overall well-being and the foundation of health. Behavior has a profound effect on organic pathologies, and pathologies impact behavior. To separate mental health from primary care makes little sense, and it is time to recognize that mental health is an important component of primary care.
Consider the evidence. Any experienced health care practitioner recognizes the immense role that mental health plays in patient care. Simply looking at the waiting area of a community health center (CHC) provides stark evidence. The medical director for one CHC estimated that “at least 85% of the patients seen at my practice have some form of comorbid mental health and physical health chronic disease.”1 Others have suggested that half the individuals in a CHC waiting area are there primarily for some recognized or unrecognized mental health issue.2 There is no doubt that this is also the case in America’s emergency departments and other primary care clinics.
People with mental health disorders have a higher mortality rate and often die prematurely due to well understood and preventable diseases such as diabetes, hypertension, respiratory problems, and infectious disorders. One need look no further than a recent issue of JAMA to understand the impact of mental health comorbidities on diabetes. Diabetic persons with depression are poorly compliant, have poor glycemic control, and experience more diabetic complications and decreased quality of life. Moreover, the economic impact of this comorbidity is staggering when the costs of increased care, unemployment, and work disability are added to the physical toll.3
With arguments as compelling and apparent as these, why then has it been so difficult to achieve meaningful levels of integration? The barriers are many. Reimbursement, legislation, and role identities are familiar reasons that an out-of-date, inefficient system continues to be propagated. But these obstacles are beginning to crumble. Providing primary care without integrating mental health is literally caring for the body and ignoring the mind. Integration of primary and mental health is now the battle cry as systems define the medical homes of the future.
Anticipating the changing environment in health care, the Substance Abuse and Mental Health Services Administration (SAMHSA) has funded a series of studies that review the diversity of approaches to mental health services and attempt to define an optimum future framework that will bring mental health back into the domain of primary care. The results of these studies were recently published as a Rand Corporation Research Report.4
Yet even as vested parties seek to identify the best practices for this integration, it is clear that the biggest challenge relates to the workforce. The logic of integration is unimpeachable and the process already in motion (unlike most changes, this one is rapidly occurring), but the supply of qualified providers is woefully inadequate.
CHCs are the largest health care system in the US and provide the “safety net” for the country’s approximately 25 million uninsured and underinsured individuals. Over the next five years, this number will grow to more than 35 million. About 70% of CHCs presently offer mental health services in some form.1 A recent survey of CHC leaders found that their biggest fear is the tidal wave of mental health problems and their ability to adequately address the needs of these patients because of a severe shortage of properly educated providers.
Psychiatrists are rare in CHCs, and those that exist focus a majority of their time on the most acutely ill. Some centers have formed alliances with community-based mental health services, but too often patient referrals don’t happen or the patient is lost to follow-up. The complex maze of reimbursement, prescribing, and follow-up makes the continued propagation of this inefficient approach unacceptable for the future.
What is needed are clinicians who are properly educated to begin to fill the gap. As such, the workforce challenges of this integration represent a significant opportunity, especially for PAs and NPs. With the exception of physicians, who are in increasingly limited supply, there are no other health care professionals who have the capability to bridge the gap between primary care and mental health. To meet the projected workforce needs, PAs and NPs will have to make a significant commitment to gain the necessary knowledge, skills, and behaviors required to treat mental health problems.
There are a number of excellent entry-level psychiatric nurse practitioner programs that prepare NPs to provide both primary and mental health care. However, most entry-level PA programs don’t have the time to do more than skim the surface of mental health care as they prepare students to begin practice as broadly educated generalist caregivers.
Fortunately, about three years ago, the National Commission on the Certification of Physician Assistants (NCCPA) began to recognize the qualifications and promote the need for PAs with advanced skills in psychiatry and mental health. As of December 2013, almost 100 PAs had successfully received a Certificate of Advanced Qualification (CAQ) in psychiatry from the NCCPA. The nation needs more than 0.1% of all PAs with a credential that recognizes their expertise in mental health. It is time to set an aggressive goal of having 1% of all PAs with a CAQ in psychiatry within the next five years.
Any PA or NP planning their future should give serious consideration to the overwhelming demand for practitioners who can effectively link primary care and mental health. This opportunity for individuals is a current reality. But even greater is the opportunity for the professions to claim a very meaningful and needed position on the health care teams of the future.
I hope you agree. Please share your thoughts with me via [email protected].
For the past two centuries, disorders of behavior have been held separate and distinct from manifestations of systemic disease that are more easily characterized by the science of the day. In the 19th century, individuals with behavioral disorders were confined to psychiatric hospitals, and in the 20th century, community mental health centers were established and funded under rules that were distinct from those of the evolving system of health care in the United States. The resulting segregation of mental health from primary care has created a crisis that plays out in the national media on a daily basis. Moreover, the continuing economic impact of maintaining this separation has profound implications for the future.
Change is upon us. Seeing the handwriting on the wall isn’t the result of a delusion. It is hard to argue that mental health is not a cornerstone of an individual’s overall well-being and the foundation of health. Behavior has a profound effect on organic pathologies, and pathologies impact behavior. To separate mental health from primary care makes little sense, and it is time to recognize that mental health is an important component of primary care.
Consider the evidence. Any experienced health care practitioner recognizes the immense role that mental health plays in patient care. Simply looking at the waiting area of a community health center (CHC) provides stark evidence. The medical director for one CHC estimated that “at least 85% of the patients seen at my practice have some form of comorbid mental health and physical health chronic disease.”1 Others have suggested that half the individuals in a CHC waiting area are there primarily for some recognized or unrecognized mental health issue.2 There is no doubt that this is also the case in America’s emergency departments and other primary care clinics.
People with mental health disorders have a higher mortality rate and often die prematurely due to well understood and preventable diseases such as diabetes, hypertension, respiratory problems, and infectious disorders. One need look no further than a recent issue of JAMA to understand the impact of mental health comorbidities on diabetes. Diabetic persons with depression are poorly compliant, have poor glycemic control, and experience more diabetic complications and decreased quality of life. Moreover, the economic impact of this comorbidity is staggering when the costs of increased care, unemployment, and work disability are added to the physical toll.3
With arguments as compelling and apparent as these, why then has it been so difficult to achieve meaningful levels of integration? The barriers are many. Reimbursement, legislation, and role identities are familiar reasons that an out-of-date, inefficient system continues to be propagated. But these obstacles are beginning to crumble. Providing primary care without integrating mental health is literally caring for the body and ignoring the mind. Integration of primary and mental health is now the battle cry as systems define the medical homes of the future.
Anticipating the changing environment in health care, the Substance Abuse and Mental Health Services Administration (SAMHSA) has funded a series of studies that review the diversity of approaches to mental health services and attempt to define an optimum future framework that will bring mental health back into the domain of primary care. The results of these studies were recently published as a Rand Corporation Research Report.4
Yet even as vested parties seek to identify the best practices for this integration, it is clear that the biggest challenge relates to the workforce. The logic of integration is unimpeachable and the process already in motion (unlike most changes, this one is rapidly occurring), but the supply of qualified providers is woefully inadequate.
CHCs are the largest health care system in the US and provide the “safety net” for the country’s approximately 25 million uninsured and underinsured individuals. Over the next five years, this number will grow to more than 35 million. About 70% of CHCs presently offer mental health services in some form.1 A recent survey of CHC leaders found that their biggest fear is the tidal wave of mental health problems and their ability to adequately address the needs of these patients because of a severe shortage of properly educated providers.
Psychiatrists are rare in CHCs, and those that exist focus a majority of their time on the most acutely ill. Some centers have formed alliances with community-based mental health services, but too often patient referrals don’t happen or the patient is lost to follow-up. The complex maze of reimbursement, prescribing, and follow-up makes the continued propagation of this inefficient approach unacceptable for the future.
What is needed are clinicians who are properly educated to begin to fill the gap. As such, the workforce challenges of this integration represent a significant opportunity, especially for PAs and NPs. With the exception of physicians, who are in increasingly limited supply, there are no other health care professionals who have the capability to bridge the gap between primary care and mental health. To meet the projected workforce needs, PAs and NPs will have to make a significant commitment to gain the necessary knowledge, skills, and behaviors required to treat mental health problems.
There are a number of excellent entry-level psychiatric nurse practitioner programs that prepare NPs to provide both primary and mental health care. However, most entry-level PA programs don’t have the time to do more than skim the surface of mental health care as they prepare students to begin practice as broadly educated generalist caregivers.
Fortunately, about three years ago, the National Commission on the Certification of Physician Assistants (NCCPA) began to recognize the qualifications and promote the need for PAs with advanced skills in psychiatry and mental health. As of December 2013, almost 100 PAs had successfully received a Certificate of Advanced Qualification (CAQ) in psychiatry from the NCCPA. The nation needs more than 0.1% of all PAs with a credential that recognizes their expertise in mental health. It is time to set an aggressive goal of having 1% of all PAs with a CAQ in psychiatry within the next five years.
Any PA or NP planning their future should give serious consideration to the overwhelming demand for practitioners who can effectively link primary care and mental health. This opportunity for individuals is a current reality. But even greater is the opportunity for the professions to claim a very meaningful and needed position on the health care teams of the future.
I hope you agree. Please share your thoughts with me via [email protected].
Managing Your Practice: What is your practice worth?
At least once during your career, you probably will have to put a value on your practice. The need arises more often than you might think – if you sell it, of course (more on that next month); but also for estate planning, preparation of financial statements, or divorce negotiations; or when an associate joins or leaves your office; or if you have occasion to combine or partner your practice with one or more others, as I will discuss in detail in a future issue.
As you might guess, a medical practice is trickier to value than an ordinary business, and usually requires the services of an experienced professional appraiser. Entire books have been written about the process, so I can’t hope to cover it completely in a few hundred words, but three basic yardsticks are essential for a practice appraisal:
Tangible assets: equipment, cash, accounts receivable, and other property owned by the practice.
Liabilities: accounts payable, outstanding loans, and anything else owed to others.
Intangible assets: sometimes called “good will” – the reputation of the physicians, the location and name recognition of the practice, the loyalty and volume of patients, and other, well, intangibles.
Armed with those numbers, an appraiser can then determine the “equity,” or book value, of the practice.
Valuing tangible assets is comparatively straightforward, but there are several ways to do it, and when reviewing a practice appraisal you should ask which of them was used. Depreciated value is the book value of equipment and supplies as determined by their purchase price, less the amount their value has decreased since purchase. Remaining useful life value estimates how long the equipment can be expected to last. Market (or replacement) value is the amount it would cost on the open market to replace all equipment and supplies.
Intangible assets are more difficult to value. Many components are analyzed, including location, interior and exterior decor, accessibility to patients, age and functional status of equipment, systems in place to promote efficiency, reasons patients come back (if they do), and the overall reputation of the practice in the community. Other important factors include the “payer mix” (what percentage pays cash, how many third-party contracts are in place and how well they pay, etc.), the extent and strength of the referral base, and the presence of clinical studies or other supplemental income streams.
It is also important to determine to what extent intangible assets are transferrable. For example, unique skills with a laser, neurotoxins, or filler substances (or extraordinary personal charisma) may increase your practice’s value to you, but they are worthless to the next owner, and he or she will be unwilling to pay for them unless your services become part of the deal.
Once again, there are many ways to estimate intangible asset value, and once again you should ask which were used. Cash flow analysis works on the assumption that cash flow is a measure of intangible value. Capitalization of earnings puts a value, or capitalization, on the practice’s income streams using a variety of assumptions. Guideline comparison uses various databases to compare your practice with other, similar ones that have changed hands in the past.
Two newer techniques, which some consider to provide a better estimate of intangible assets, are the replacement method, which estimates the costs of starting the practice over again in the current market; and the excess earnings method, which measures how far above average your practice’s earnings are (and thus its overall value).
Asset-based valuation is the most popular, but by no means the only, method available. Income-based valuation looks at the source and strength of a practice’s income stream as a creator of value, as well as whether or not the income stream under a different owner would mirror its present one. This in turn becomes the basis for an understanding of the fair market value of both tangible and intangible assets. Market valuation combines the asset-based and income-based approaches, along with an analysis of sales and mergers of comparable practices in the community, to determine the value of a practice in its local market.
Whatever methods are used, it is important that the appraisal be done by an experienced financial consultant, that all techniques used in the valuation be divulged and explained, and that documentation is supplied to support the conclusions reached. This is especially important if the appraisal will be relied upon in the sale or merger of the practice. I’ll talk about sales and mergers over the next several columns.
Dr. Eastern practices dermatology and dermatologic surgery in Belleville, N.J. He is the author of numerous articles and textbook chapters, and is a longtime monthly columnist for Skin & Allergy News.
At least once during your career, you probably will have to put a value on your practice. The need arises more often than you might think – if you sell it, of course (more on that next month); but also for estate planning, preparation of financial statements, or divorce negotiations; or when an associate joins or leaves your office; or if you have occasion to combine or partner your practice with one or more others, as I will discuss in detail in a future issue.
As you might guess, a medical practice is trickier to value than an ordinary business, and usually requires the services of an experienced professional appraiser. Entire books have been written about the process, so I can’t hope to cover it completely in a few hundred words, but three basic yardsticks are essential for a practice appraisal:
Tangible assets: equipment, cash, accounts receivable, and other property owned by the practice.
Liabilities: accounts payable, outstanding loans, and anything else owed to others.
Intangible assets: sometimes called “good will” – the reputation of the physicians, the location and name recognition of the practice, the loyalty and volume of patients, and other, well, intangibles.
Armed with those numbers, an appraiser can then determine the “equity,” or book value, of the practice.
Valuing tangible assets is comparatively straightforward, but there are several ways to do it, and when reviewing a practice appraisal you should ask which of them was used. Depreciated value is the book value of equipment and supplies as determined by their purchase price, less the amount their value has decreased since purchase. Remaining useful life value estimates how long the equipment can be expected to last. Market (or replacement) value is the amount it would cost on the open market to replace all equipment and supplies.
Intangible assets are more difficult to value. Many components are analyzed, including location, interior and exterior decor, accessibility to patients, age and functional status of equipment, systems in place to promote efficiency, reasons patients come back (if they do), and the overall reputation of the practice in the community. Other important factors include the “payer mix” (what percentage pays cash, how many third-party contracts are in place and how well they pay, etc.), the extent and strength of the referral base, and the presence of clinical studies or other supplemental income streams.
It is also important to determine to what extent intangible assets are transferrable. For example, unique skills with a laser, neurotoxins, or filler substances (or extraordinary personal charisma) may increase your practice’s value to you, but they are worthless to the next owner, and he or she will be unwilling to pay for them unless your services become part of the deal.
Once again, there are many ways to estimate intangible asset value, and once again you should ask which were used. Cash flow analysis works on the assumption that cash flow is a measure of intangible value. Capitalization of earnings puts a value, or capitalization, on the practice’s income streams using a variety of assumptions. Guideline comparison uses various databases to compare your practice with other, similar ones that have changed hands in the past.
Two newer techniques, which some consider to provide a better estimate of intangible assets, are the replacement method, which estimates the costs of starting the practice over again in the current market; and the excess earnings method, which measures how far above average your practice’s earnings are (and thus its overall value).
Asset-based valuation is the most popular, but by no means the only, method available. Income-based valuation looks at the source and strength of a practice’s income stream as a creator of value, as well as whether or not the income stream under a different owner would mirror its present one. This in turn becomes the basis for an understanding of the fair market value of both tangible and intangible assets. Market valuation combines the asset-based and income-based approaches, along with an analysis of sales and mergers of comparable practices in the community, to determine the value of a practice in its local market.
Whatever methods are used, it is important that the appraisal be done by an experienced financial consultant, that all techniques used in the valuation be divulged and explained, and that documentation is supplied to support the conclusions reached. This is especially important if the appraisal will be relied upon in the sale or merger of the practice. I’ll talk about sales and mergers over the next several columns.
Dr. Eastern practices dermatology and dermatologic surgery in Belleville, N.J. He is the author of numerous articles and textbook chapters, and is a longtime monthly columnist for Skin & Allergy News.
At least once during your career, you probably will have to put a value on your practice. The need arises more often than you might think – if you sell it, of course (more on that next month); but also for estate planning, preparation of financial statements, or divorce negotiations; or when an associate joins or leaves your office; or if you have occasion to combine or partner your practice with one or more others, as I will discuss in detail in a future issue.
As you might guess, a medical practice is trickier to value than an ordinary business, and usually requires the services of an experienced professional appraiser. Entire books have been written about the process, so I can’t hope to cover it completely in a few hundred words, but three basic yardsticks are essential for a practice appraisal:
Tangible assets: equipment, cash, accounts receivable, and other property owned by the practice.
Liabilities: accounts payable, outstanding loans, and anything else owed to others.
Intangible assets: sometimes called “good will” – the reputation of the physicians, the location and name recognition of the practice, the loyalty and volume of patients, and other, well, intangibles.
Armed with those numbers, an appraiser can then determine the “equity,” or book value, of the practice.
Valuing tangible assets is comparatively straightforward, but there are several ways to do it, and when reviewing a practice appraisal you should ask which of them was used. Depreciated value is the book value of equipment and supplies as determined by their purchase price, less the amount their value has decreased since purchase. Remaining useful life value estimates how long the equipment can be expected to last. Market (or replacement) value is the amount it would cost on the open market to replace all equipment and supplies.
Intangible assets are more difficult to value. Many components are analyzed, including location, interior and exterior decor, accessibility to patients, age and functional status of equipment, systems in place to promote efficiency, reasons patients come back (if they do), and the overall reputation of the practice in the community. Other important factors include the “payer mix” (what percentage pays cash, how many third-party contracts are in place and how well they pay, etc.), the extent and strength of the referral base, and the presence of clinical studies or other supplemental income streams.
It is also important to determine to what extent intangible assets are transferrable. For example, unique skills with a laser, neurotoxins, or filler substances (or extraordinary personal charisma) may increase your practice’s value to you, but they are worthless to the next owner, and he or she will be unwilling to pay for them unless your services become part of the deal.
Once again, there are many ways to estimate intangible asset value, and once again you should ask which were used. Cash flow analysis works on the assumption that cash flow is a measure of intangible value. Capitalization of earnings puts a value, or capitalization, on the practice’s income streams using a variety of assumptions. Guideline comparison uses various databases to compare your practice with other, similar ones that have changed hands in the past.
Two newer techniques, which some consider to provide a better estimate of intangible assets, are the replacement method, which estimates the costs of starting the practice over again in the current market; and the excess earnings method, which measures how far above average your practice’s earnings are (and thus its overall value).
Asset-based valuation is the most popular, but by no means the only, method available. Income-based valuation looks at the source and strength of a practice’s income stream as a creator of value, as well as whether or not the income stream under a different owner would mirror its present one. This in turn becomes the basis for an understanding of the fair market value of both tangible and intangible assets. Market valuation combines the asset-based and income-based approaches, along with an analysis of sales and mergers of comparable practices in the community, to determine the value of a practice in its local market.
Whatever methods are used, it is important that the appraisal be done by an experienced financial consultant, that all techniques used in the valuation be divulged and explained, and that documentation is supplied to support the conclusions reached. This is especially important if the appraisal will be relied upon in the sale or merger of the practice. I’ll talk about sales and mergers over the next several columns.
Dr. Eastern practices dermatology and dermatologic surgery in Belleville, N.J. He is the author of numerous articles and textbook chapters, and is a longtime monthly columnist for Skin & Allergy News.